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I Summary 
GABAB receptors are metabotropic receptors of the prevalent inhibitory neurotransmitter gamma‐
aminobutyric acid (GABA), playing important roles in modulating overall neurotransmission and synaptic 
plasticity processes. The two principal subunits GABAB1 and GABAB2 form an obligate heterodimeric 
receptor, which is coupled to Gi/o (reviewed in Gassmann and Bettler, 2012). Additionally, GABAB 
receptors are found in complexes with members of a subfamily of potassium channel tetramerization 
domain proteins (KCTDs). Precisely, KCTD8, KCTD12, KCTD12b and KCTD16 function as auxiliary subunits, 
further increasing molecular diversity of GABAB receptors and specifically modulating receptor 
responses, e.g. KCTD12‐mediated desensitization of GABAB responses (Schwenk et al., 2010, Turecek et 
al., 2014). It has been described that GABAB receptors together with their KCTD subunits are present in 
large signaling complexes, e.g. in conjunction with the presynaptic N‐type voltage‐gated calcium 
channels and elements of the synaptic release machinery (Müller et al., 2010). However, the precise 
function of KCTDs in these complexes is not fully understood at the moment. 
This thesis aims to study some of the roles that the KCTD subunits play in GABAB signaling, especially 
with regard to the interconnection of GABAB receptors to downstream signaling complexes. The main 
hypothesis was that KCTDs are molecular scaffolds for these protein complexes, thereby enlarging the 
functional repertoire of GABAB receptors. 
The thesis is divided in two independent chapters. In the first chapter, I found that KCTD8 and KCTD16 
are novel interactors of Cullin 3‐RING E3 ubiquitin ligases (CRL3). The hypothesis that the GABAB‐
associated KCTDs may bind to Cullin 3 was based on the fact that other KCTD family members were 
shown to be CRL3 substrate adaptors (Skoblov et al., 2013). Surprisingly, these newly‐discovered 
interactions with Cullin 3 depended on the homology 2 (H2) domains of KCTD16 and KCTD8, even though 
Cullin 3‐interactions of other KCTD family members are mediated by so‐called Bric‐a‐brac, Tramtrack, 
Broad‐complex (BTB) motifs found in their tetramerization (T1) domains (Furukawa et al., 2003, Skoblov 
et al., 2013). In the case of KCTD8 and KCTD16, their T1 domains were shown to lack Cullin 3‐binding. 
Similar to other BTB substrate adaptors, KCTD16 was found to bind to the N‐terminus of Cullin 3. The 
unusual Cullin 3‐binding domains of KCTD16 and KCTD8 were confirmed by BRET measurements. Finally, 
I found that KCTD16 provides a linker between the GABAB receptor and the Cullin 3 complex. Co‐
expression of KCTD16 with GABAB receptors did not down‐regulate GABAB receptors. Thus, the 
functional consequences of these novel CRL3 complexes are still unknown. 
In the second chapter, I studied the function of the KCTDs in the complex of GABAB receptors and N‐type 
voltage‐gated calcium channels (VGCCs). I discovered that the CaV2.2 α1 subunit specifically interacts 
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with KCTD16 but not with KCTD12 and KCTD8. Interaction domain‐mapping showed that this CaV2.2‐
KCTD16 interaction relied on the H2 domain of KCTD16. Strikingly, the CaV2.2‐binding property could be 
transferred to KCTD12 by fusing the H2 domain of KCTD16 to KCTD12. Interestingly, the Gβγ‐binding 
intracellular loop I‐II of CaV2.2 was sufficient for the association with KCTD16. Finally, I confirmed the 
protein‐protein interactions of GABAB receptors with both CaV2.2 and the synaptic protein syntaxin‐1 in 
mouse brain tissue in co‐IP experiments. 
To understand the physiological relevance of this direct CaV2.2‐KCTD16 interaction, its 
electrophysiological effects were characterized. It was found that KCTD16 changes the biophysical 
properties of N‐type VGCCs in several ways. First, KCTD16 shifts the voltage‐dependence of the channel 
to more hyperpolarized potentials. Second, KCTD16 increases the permeability of N‐type VGCCs for 
divalent cations. Third, KCTD16 accelerates the kinetics of the channel activation. Perhaps most 
important for in vivo function, KCTD16 decreases the sensitivity and speed of response of N‐type VGCCs 
to GABAB‐mediated inhibition. 
In conclusion, the results of this thesis corroborate the concept that GABAB receptor‐associated KCTDs 
act as molecular linkers of GABAB receptors to downstream signaling complexes, as shown here for CRL3 
and N‐type VGCCs. Furthermore, the results presented here also have functional implications for GABAB‐
modulation of presynaptic neurotransmitter release. 
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II Abbreviations 
AID   Alpha interaction domain (of VGCCs) 
BACURD BTB/POZ domain‐containing adapter for Cul3‐mediated RhoA degradation 
protein 
BRET    Bioluminescence resonance energy transfer 
BTB    Bric‐a‐brac, Tramtrack, Broad‐complex domain 
CaV2.1   Pore‐forming α1 subunit of P/Q‐type voltage‐gated calcium channels 
CaV2.2   Pore‐forming α1 subunit of N‐type voltage‐gated calcium channels 
CaMKII   Calmodulin‐dependent kinase II 
CHO   Chinese hamster ovary cells 
CHO N‐VGCC  CHO cell line stably expressing N‐type VGCC 
CNS   Central nervous system 
Co‐IP   Co‐immunoprecipitation 
COS‐1   Immortalized African green monkey cell line 
CRL    Cullin‐RING E3 ligase 
Cul1   Cullin 1 
Cul3   Cullin 3 
E1, E2, E3  Enzymes of the ubiquitination cascade 
ER    Endoplasmic reticulum 
ERAD   Endoplasmic reticulum‐associated degradation 
GABA   Gamma‐aminobutyric acid 
GABAA   Gamma‐aminobutyric acid type A 
GABAB   Gamma‐aminobutyric acid type B 
GHB   Gamma‐hydroxybutyric acid 
GIRK   G‐protein‐gated inwardly rectifying potassium channel 
GK   Guanylate kinase 
GPCR   G protein‐coupled receptor 
GRK   G protein‐coupled receptor kinase 
H1   Homology domain 1 (of KCTDs) 
H2    Homology domain 2 (of KCTDs) 
HCN2   Hyperpolarization‐activated cyclic nucleotide–gated cation channel 2 
HDAC1   Histone deacetylase 1 
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HEK293T  Human Embryonic Kidney 293 cells containing the large T antigen 
HVA   High‐voltage‐activated (calcium channels) 
IP   Immunoprecipitation 
IPSP   Inhibitory postsynaptic potential 
KCTD   Potassium channel tetramerization domain protein 
Kir   Potassium inwardly‐rectifying channel 
KO   Knock‐out 
LTP   Long‐term potentiation 
LVA   Low‐voltage‐activated (calcium channels) 
NMDA   N‐methyl‐D‐aspartate receptor 
PAM   Positive allosteric modulator 
PKA   cAMP‐dependent protein kinase 
PKC    Protein kinase C 
POZ    Pox virus and zinc finger (domain) 
PTX   Pertussis toxin 
RING   Really Interesting New Gene 
Rluc   Renilla reniformis luciferase 
SH3    Src homology 3 
SNARE   Soluble N‐ethylmaleimide‐sensitive‐factor attachment receptor 
SNP   Single nucleotide polymorphism 
Synprint   Synaptic protein interaction domain (of VGCCs) 
Syt11   Synaptotagmin 11 
T1   Tetramerization domain (of KCTDs) 
Ub   Ubiquitin 
VFTD   Venus flytrap domain 
WT    Wild‐type 
YFP   Yellow fluorescent protein 
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III General Introduction 
GABAB receptors 
Gamma‐aminobutyric acid (GABA) is the prevalent inhibitory neurotransmitter in the brain. The 
receptors for GABA can be classified into the GABAA ion channels and the metabotropic GABAB receptors 
(Olsen and Sieghart, 2008). Both GABAA and GABAB receptors mediate inhibitory postsynaptic potentials 
(IPSP). The ionotropic GABAA receptors are responsible for fast IPSPs acting within the order of a few 
milliseconds (Olsen and Sieghart, 2008). On the other hand, postsynaptic activation of metabotropic 
GABAB‐receptors causes slower IPSPs with durations of hundreds of milliseconds (reviewed in Gassmann 
and Bettler, 2012). 
GABAB receptors belong to the family C of GPCRs and are structurally related to metabotropic glutamate 
receptors (Pin et al., 2003). Classical work of Bowery et al. showed that there are GABA receptors that 
are bicuculline‐insensitive, these unusual GABA receptors were then termed GABAB receptors (reviewed 
in Bowery, 1993). The molecular cloning of the principal GABAB receptor subunits was accomplished in 
the late 1990s (Kaupmann et al., 1997). On a molecular level, GABAB receptors consist of two principal 
subunits, so‐called GABAB1 and GABAB2 (Kaupmann et al., 1998a). Like other members of the GPCR family 
C, both GABAB receptor subunits are consisting of an N‐terminal signal peptide, a large extracellular 
Venus flytrap domain (VFTD), a seven‐transmembrane domain and an intracellular C‐terminus important 
for signaling (Pin et al., 2003). The VFTD harbors the ligand‐binding site in GABAB1. The GABAB1 subunit 
exists in two different isoforms, GABAB1a and GABAB1b, differing by the two sushi domains which are only 
present in GABAB1a (Gassmann and Bettler, 2012). The sushi domains of GABAB1a have a role in axonal 
trafficking, causing a different subcellular distribution in neurons for GABAB1a and GABAB1b (Vigot et al., 
2006, Biermann et al., 2010). However, GABAB1a and GABAB1b do not differ pharmacologically when 
expressed in heterologous cells (Bettler et al., 2004). Functional GABAB receptors are formed by an 
obligate heterodimer of GABAB1 and GABAB2, as GABAB1 KO or GABAB2 KO mice lack electrophysiological 
GABAB responses and display strong behavioral abnormalities such as stereotypical circling. The 
phenotypes of GABAB KO mice are summarized elsewhere (table 1 in Gassmann and Bettler, 2012). Even 
though GABAB1 contains the ligand‐binding site, it is not sufficient to form a functional GABAB receptor 
on its own, because GABAB2 is required for efficient trafficking of GABAB1 to the plasma membrane 
(Pagano et al., 2001, Robbins et al., 2001). GABAB1 is retained by an ER retention motif (RSRR) contained 
on its intracellular domain that is occluded when GABAB1 and GABAB2 heterodimerize in the ER (Pagano 
et al., 2001). In addition to the role in trafficking, GABAB2 is also important for G protein‐coupling and 
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contains the binding site for the auxiliary KCTD subunits (Robbins et al., 2001, Schwenk et al., 2010). 
GABAB receptors belong to the class of Gi/o‐coupled receptors (Bettler et al., 1998). Activation of GABAB 
receptors by GABA or pharmacological agonists such as baclofen leads to the dissociation of Gα and Gβγ 
from the receptor. Gα inhibits adenylate cyclase and Gβγ signals to downstream effector channels such 
as G‐protein‐gated inwardly rectifying potassium (GIRK) channels or N‐type VGCCs (Gassmann and 
Bettler, 2012). 
Figure 1. Major effector systems of the GABAB receptor at the pre- and postsynapse. 
GABAB receptors are Gi/o‐coupled GPCRs. Activation of the GABAB receptor leads to the dissociation of 
the heterotrimeric G protein. (A) At the presynapse, Gβγ inhibits presynaptic VGCCs and consequentially 
neurotransmitter release, while Gα inhibits the adenylate cyclase and thus affects spontaneous release 
of neurotransmitters. (B) At the postsynapse, released Gβγ activates GIRK channels, thereby leading to 
slow IPSPs. Furthermore, Gβγ decreases dendritic calcium spikes by inhibiting postsynaptic VGCCs. Gα 
inhibits PKA signaling via inhibition of the adenylate cyclase. Figure adapted from (Gassmann and Bettler, 
2012). 
A
B
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In neurons, GABAB receptors are expressed in both presynaptic and postsynaptic locations (Vigot et al., 
2006). Figure 1 illustrates the most important signaling pathways of pre‐ and postsynaptic GABAB 
receptors. GABAB receptors are found in almost all neurons in the brain. At the presynapse, activation of 
GABAB receptors leads to inhibition of neurotransmission via Gβγ‐inhibition of presynaptic voltage‐gated 
calcium channels and Gα‐mediated inhibition of the adenylate cyclase (Gassmann and Bettler, 2012).  
Postsynaptic GABAB receptors located in the somatodendritic compartment cause a reduction of 
neuronal excitability by several mechanisms. Release of the Gβγ heterodimer activates GIRK channels, 
leading to slow IPSPs and additionally inhibits postsynaptic VGCCs (Sodickson and Bean, 1996, Kaupmann 
et al., 1998b, Pérez‐Garci et al., 2006). Gα‐signaling inhibits the adenylate cyclase causing reduced PKA 
activity, which in turn affects NMDA receptors and TREK2 channels (Deng et al., 2009, Chalifoux and 
Carter, 2010). 
The GABAB receptor is regulated on several levels. First, GABAB receptor complexes are regulated by 
their subunit composition, as the KCTD subunits have differential effects on GABAB signaling (Schwenk et 
al., 2010). Second, GABAB membrane levels are regulated through mechanisms like endocytosis, 
degradation or trafficking. GPCRs often undergo agonist‐dependent internalization. The molecular 
mechanism involves receptor phosphorylation by G protein‐coupled receptor kinases (GRKs) and β 
arrestin recruitment. Internalized receptors can then be either recycled back to the plasma membrane or 
degraded by lysosomal degradation. GABAB receptors do not undergo this classical agonist‐dependent 
internalization (Raveh et al., 2015). Instead, GABAB receptors are constitutively internalized and 
glutamatergic neurotransmission leads to a decrease in GABAB receptor levels by reducing the fraction of 
recycled receptors (Maier et al., 2010). In another study, NMDA receptor activity was shown to cause 
GABAB receptor internalization by CaMKII‐phosphorylation at S867 in the c‐tail of GABAB1 subunit (Guetg 
et al., 2010). PKA‐mediated phosphorylation of GABAB2 at S892 increases receptor stability by inhibiting 
constitutive receptor endocytosis (Couve et al., 2002). Proteasomal degradation also influences plasma 
membrane GABAB levels, as blocking the endoplasmic reticulum‐associated degradation (ERAD) pathway 
leads to increased GABAB receptor levels (Zemoura et al., 2013). This form of degradation of GABAB is 
mediated by the ERAD E3 ligase Hrd1, which ubiquitinates the intracellular lysines 767/771 of GABAB2 
with K48‐linked‐polyubiquitin chains (Zemoura et al., 2013). K48‐polyubiquitination is a classical signal 
for proteasomal degradation (Thrower et al., 2000). 
Synaptic plasticity, the phenomenon of changing individual synaptic connections between neurons by 
long‐term potentiation (LTP) or its opposite long‐term depression (LTD), is widely thought to be crucial 
for learning and memory (reviewed in Sweatt, 2016). GABAB receptors are well known to regulate 
General Introduction 
 
‐ 14 ‐ 
synaptic strength by LTP (Davies et al., 1991). Given the importance of GABAB receptors in the brain, it is 
not surprising that GABAB–signaling has been implicated in many neurological diseases such as epilepsy, 
depression, addiction and anxiety (reviewed in Gassmann and Bettler, 2012). 
Only two drugs with GABAB‐affinity are in clinical use nowadays, notably the archetypical GABAB‐specific 
agonist baclofen has clinical utility as a muscle relaxant for treating spasticity (Bettler et al., 2004). The 
property as a muscle relaxant and other side effects like sedation or confusion make baclofen 
unfavorable for treating psychiatric disorders (Bettler et al., 2004). Gamma‐hydroxybutyric acid (GHB) is 
a substance naturally occurring in the brain in trace amounts as well as a psychoactive compound, when 
administered exogenously. GHB is known to act as a GABAB receptor agonist, but has diverse effects on 
other pathways as well (Maitre et al., 2016). However, it is unknown whether the low concentrations of 
GHB found in healthy people affect GABAB signaling (Gassmann and Bettler, 2012). In a metabolic 
disease called succinic semialdehyde dehydrogenase deficiency, high amounts of GHB accumulate in the 
brain due to lack of degradation (Maitre et al., 2016). Due to its depressant properties, GHB is utilized in 
the treatment of narcolepsy and as a therapeutic substitute for alcohol (Leone et al., 2010, Gowda and 
Lundt, 2014). Furthermore, GHB is illicitly used as a recreational drug and date‐rape drug (Maitre et al., 
2016).  
The GABAB antagonist SGS742 was tested in Phase II clinical studies for mild cognitive impairment and 
Alzheimer’s disease, but the clinical development for this indication was discontinued later (Froestl et al., 
2004). Positive allosteric modulators (PAMs) of GABAB receptors are promising for a number of diseases 
such as addiction and are currently being developed by pharmaceutical companies (Filip et al., 2015). 
Compared to GABAB agonists, the GABAB PAMs are supposed to modulate the GABAB receptors in a more 
physiological way, because they only enhance signaling that is already present endogenously. This 
mechanism of action improves their safety and side effect profile (Filip et al., 2015). PAMs are thought to 
bind to the transmembrane domain of GABAB2 and consequentially influence GABAB signaling (Urwyler, 
2011).  
 
KCTDs as auxiliary GABAB receptor subunits 
For some time, several elements of electrophysiological GABAB responses recorded in native tissue could 
not be fully explained with the respective responses in recombinant cells expressing the two principal 
GABAB receptor subunits (Gassmann and Bettler, 2012). This fact pointed towards more underlying 
molecular complexity. In a proteomics analysis of native GABAB complexes, the intracellular proteins 
KCTD12, KCTD12b, KCTD16 and KCTD8 were found and proposed as auxiliary subunits of the GABAB 
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receptor (Schwenk et al., 2010), on the basis of their stable and tight association with GABAB receptors. 
Furthermore, they specifically modulate GABAB receptor responses, e.g. KCTD12 plays a role in the fast 
desensitization of GABAB‐mediated GIRK currents (Schwenk et al., 2010, Adelfinger et al., 2014, Turecek 
et al., 2014). The existence of KCTD auxiliary subunits could partially explain some differences seen 
between recombinant and native GABAB responses, however an important discrepancy still remains 
unexplained, namely the 10‐fold higher agonist affinity seen in native brain membranes compared to 
recombinant systems (Kaupmann et al., 1998a, Rajalu et al., 2015). 
The KCTD protein family encompasses at least 26 different intracellular proteins involved in diverse 
cellular functions like development, proliferation, protein degradation, transcription regulation and 
regulation of potassium conductances (Skoblov et al., 2013). All KCTD proteins contain an eponymous 
tetramerization domain (T1 domain), which exhibits homology to the tetramerization domain found in 
potassium channels (Liu et al., 2013). The KCTD family of proteins belongs to the larger family of BTB 
domain proteins, as their T1 domains contain the BTB structural motif (Skoblov et al., 2013). BTB 
proteins are thought to be the substrate adaptors for the Cullin 3‐RING E3 ubiquitin ligases (Furukawa et 
al., 2003). 
KCTD8, KCTD12, KCTD12b and KCTD16 share their overall protein domain structure and constitute one 
subclade of the KCTD family (Schwenk et al., 2010, Liu et al., 2013). Their protein domain structure is 
shown in Fig. 2A. They all contain the T1 domain at their very N‐terminus followed by the homology 
domain 1 (H1 domain) (Skoblov et al., 2013). KCTD8 and KCTD16 additionally possess the homology 
domain 2 (H2 domain) at their very C‐terminus (Schwenk et al., 2010). Both H1 and H2 domains do not 
resemble any known protein domain found in other proteins and are also not related to each other. As 
all KCTD proteins feature a tetramerization domain, the KCTD proteins are thought to form oligomers, 
e.g. for KCTD5 a pentameric stoichiometry was observed (Dementieva et al., 2009). In the case of the 
GABAB‐associated KCTD proteins, it is assumed that they all form tetramers (Schwenk et al., 2010). The 
gene coding for KCTD12b is found in many vertebrates, but humans only possess KCTD8, KCTD12 and 
KCTD16 (Seddik et al., 2012, Skoblov et al., 2013). 
The expression pattern of the GABAB‐associated KCTDs is subtype‐specific (Fig. 2B) and not restricted to 
neuronal tissue, therefore at least some of these KCTDs may have additional roles other than GABAB‐
modulation (Schwenk et al., 2010, Metz et al., 2011). For example, KCTD12 can be found in many tissues 
like intestine, colon, kidney, heart, testis and bone marrow and is reported to be relevant in some 
gastrointestinal tumors (Suehara et al., 2008, Kikuta et al., 2010, Metz et al., 2011). In the adult mouse 
brain, KCTD12 and KCTD16 are most widely expressed, whereas the distributions of KCTD8 and KCTD12b 
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are quite confined to specific brain areas (Metz et al., 2011). KCTD12b is found exclusively in the medial 
habenula. KCTD8 is localized in the medial habenula, cerebellum and in parts of the brainstem. KCTD12 is 
found in several brain regions like the hippocampus and the cerebellum. KCTD16 is widely expressed in 
the cortex, hippocampus, thalamus and amygdala. Pyramidal and granule cells in the hippocampus can 
express both KCTD12 and KCTD16, so their expression is not mutually exclusive (Metz et al., 2011). 
 
Figure 2. KCTD proteins are auxiliary subunits of the GABAB receptor.  
(A) Schematic illustration of the protein domain structure of the GABAB‐associated KCTDs. All contain a 
T1 domain, where the GABAB2‐binding site is located and a H1 domain, which enables G protein‐binding. 
KCTD8 and KCTD16 feature an additional H2 domain, which enables further protein‐interactions.  
(B) KCTD tissue distribution in adult mice brains as observed by in situ hybridization. KCTD12 and KCTD16 
are widely expressed, e.g. in the hippocampus. In contrast, the expression of KCTD8 and KCTD12b is 
restricted to a few brain areas, such as the medial habenula. Panel adapted from (Schwenk et al., 2010) 
(C) KCTDs affect GABAB‐effector channel signaling by interacting with Gβγ. As shown here, KCTD12 
mediates desensitization of GIRK currents by inhibiting the Gβγ‐activation of the GIRK channel. Panel 
adapted from (Raveh et al., 2015). 
 
KCTD8, KCTD12, KCTD12b and KCTD16 are binding to the intracellular tail of GABAB2 through their T1 
domains (Schwenk et al., 2010). Residues 901‐906 of GABAB2 are particularly important, as the point 
mutation Y902A abolishes KCTD‐binding (Schwenk et al., 2010). Interestingly, this critical Y902 residue is 
conserved among vertebrates but absent in invertebrates, therefore the function of KCTDs as GABAB‐
associated subunits evolved in vertebrates (Seddik et al., 2012). The specific H1 domain of KCTD12 and 
GABAB heterodimer GIRK channel GABA 
KCTD12-mediated 
desensitization 
GABAB-activation leads 
to GIRK opening 
GABAB receptor complex 
with G proteins and KCTD12 
A B 
C 
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the absence of an H2 domain are important for the KCTD12‐mediated desensitization of the GABAB 
response (Seddik et al., 2012). KCTD8, KCTD12 and KCTD16 are also known to interact with G proteins 
even in the absence of the GABAB receptor (Turecek et al., 2014). They specifically bind to the Gβγ 
heterodimer and also to the trimeric G protein complex (Turecek et al., 2014). Their isolated H1 domain 
is sufficient for interaction with the G proteins (T. Fritzius, personal communication). Besides its 
inhibitory role in desensitization, the H2 domain of KCTD16 is known to interact with the HCN2 channel 
and 14‐3‐3 proteins (Schwenk et al., 2016). 
Even though GABAB‐associated KCTDs do not have a major allosteric effect on ligand‐binding to the 
GABAB receptor per se (Rajalu et al., 2015), GABAB‐mediated GIRK currents differ significantly depending 
on the molecular composition of individual GABAB receptor complexes. GABAB receptors associated with 
KCTD12 and KCTD12b showed strong desensitization, whereas KCTD8 and KCTD16 displayed much less 
desensitization in the continued presence of baclofen (Schwenk et al., 2010). The mechanism for this 
desensitization is illustrated in Fig. 2C. The same pattern of response kinetics was observed when the 
GABAB‐regulated CaV2.1‐ and CaV2.2‐currents were studied in oocytes (Schwenk et al., 2010). All four 
KCTDs accelerate the rise‐time of the GIRK‐mediated GABAB receptor response, but differ individually in 
the degree of acceleration (Schwenk et al., 2010). KCTD12 and KCTD16 also strongly increase agonist 
potency for GABAB receptors (Schwenk et al., 2010). 
GABAB‐associated KCTDs have been implicated in a number of diseases. As GABAB receptor signaling 
itself is known to be implicated in many neuropsychological disorders such as epilepsy, it is not surprising 
that the auxiliary KCTDs also have some importance for this type of diseases. In this context, a genome‐
wide association study (GWAS) implicated KCTD12 in bipolar I disorder in a population sample of Han 
Chinese (Lee et al., 2011). In another study, the expression of KCTD12 was found to be upregulated in 
the hippocampus of schizophrenic patients (Benes, 2009). KCTD12 was also identified as a risk modifier 
in chronic tinnitus (Sand et al., 2012). Furthermore, KCTD12 is relevant for depression, as KCTD12 is 
upregulated in the amygdala of patients with major depressive disorder (Surget et al., 2008, Sibille et al., 
2009). Another genetic study identified KCTD16 as a candidate gene for a special form of inherited 
temporal lobe epilepsy, but a molecular mechanism for this was not proposed (Angelicheva et al., 2009). 
Given their tissue expression profiles, the GABAB‐associated KCTDs likely play GABAB‐independent roles 
too, therefore these proteins could be relevant for diseases in a broader context (Metz et al., 2011). A 
large body of work showed that the KCTD12 expression level is a robust prognostic marker in 
gastrointestinal tumors (Suehara et al., 2008, Kikuta et al., 2010, Kubota et al., 2012, Hasegawa et al., 
2013, Kubota et al., 2013, Orita et al., 2014). Similar to gastrointestinal tumors, KCTD12‐positivity also 
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leads to a better survival prognosis for sarcoma patients (Kondo et al., 2013). KCTD12 was also analyzed 
in the context of glucose regulation and diabetes, but found to be of comparatively little importance 
(Cauchi et al., 2008). 
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IV Aim of the Thesis 
GABAB receptors are metabotropic receptors for the prevalent inhibitory neurotransmitter in the brain 
GABA. A large body of work already clarified the basic molecular constituents of functional GABAB 
receptors and their general electrophysiological responses (Gassmann and Bettler, 2012). Recently, it 
became apparent that GABAB receptors together with their auxiliary subunits KCTD8, KCTD12 and 
KCTD16 are found in large protein complexes in vivo, e.g. GABAB receptors are linked to N‐type VGCCs 
and synaptic proteins of the presynaptic release machinery (Müller et al., 2010, Schwenk et al., 2010, 
Schwenk et al., 2016). The precise biochemical constitution of these signaling complexes and their 
functional consequences are still unclear. 
The main goal of this thesis was to study novel protein interactions of the GABAB‐associated KCTDs, in 
order to gain more knowledge about the interconnections of GABAB receptors to other protein 
complexes. This thesis is based on two chapters: In the first chapter, I wanted to test the hypothesis that 
GABAB‐associated KCTDs are novel interactors of Cullin 3‐RING E3 ubiquitin ligases (CRL3). In the second 
chapter, I wanted to study the function of KCTDs in the interaction of GABAB receptors with N‐type 
voltage‐gated calcium channels. 
In chapter one, the hypothesis that KCTD12, KCTD16 and KCTD8 may be novel interactors of Cullin 3‐
RING E3 ubiquitination ligases was investigated (see 1.3.1). This hypothesis is mainly based on the 
homology between different KCTD family protein members. Most of the KCTD proteins have been found 
to be interacting with Cul3; for some KCTDs a substrate adaptor function has been demonstrated 
(Skoblov et al., 2013). The discovered Cul3‐KCTD16 and Cul3‐KCTD8 protein‐protein interactions were 
then further characterized in terms of the necessary protein domains (see 1.3.2 and 1.3.3). As I found 
that the Cul3‐KCTD16 interaction was dependent on an unexpected protein domain (the H2 domain 
rather than the T1 domain), I wanted to confirm this finding by another method. Therefore, I decided to 
do BRET measurements to corroborate my previous interaction domain‐mapping (see 1.3.4). Based on 
the results of the interaction domain‐mapping, the hypothesis that KCTD16 and KCTD8 are molecular 
linkers for Cullin 3 and GABAB receptors was studied (1.3.5). Finally, the plausible hypothesis that KCTD16 
plays a role in the constitutive degradation of GABAB receptors was tested (1.3.6). 
In chapter two, I wanted to study the important presynaptic complex of GABAB receptors with N‐type 
voltage gated calcium channels, particularly the role that KCTDs play in this complex. First, I wanted to 
study whether the GABAB auxiliary subunits KCTD8, KCTD12 or KCTD16 interact with N‐type calcium 
channels (see 2.3.1 and 2.3.2). I then decided to further characterize the newly‐discovered CaV2.2‐
KCTD16 interaction (see 2.3.3 and 2.3.4). Finally, I chose to confirm the biochemical interactions of the 
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GABAB receptor with N‐type VGCCs and the synaptic protein syntaxin‐1 in mouse brain membranes (see 
2.3.5). In order to understand the physiological relevance of the CaV2.2‐KCTD16 interaction, 
electrophysiological recordings were carried out (R. Turecek), see 2.3.6. 
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Chapter 1: KCTD8 and KCDT16 are novel Cullin 3-interactors 
1.1 Introduction 
1.1.1 Ubiquitination 
Ubiquitination is the process of modifying protein substrates with a protein called Ubiquitin (Ub). Ub 
itself is a small (8.5kDa) and highly conserved protein in eukaryotes, is expressed ubiquitously and 
comprises only 76 amino acid residues (Goldstein et al., 1975). Since its Nobel‐prized discovery in the 
1980s, ubiquitination has emerged as an important post‐translational modification rivalling 
phosphorylation, reflected by the fact that several thousands of proteins are regulated by some form of 
ubiquitination (Wilkinson, 2005, Kim et al., 2011, Wagner et al., 2011). Ubiquitination occurs in many 
different ways (reviewed in Komander and Rape, 2012). The least complex form of ubiquitination is 
mono‐ubiquitination, where exactly one ubiquitin moiety is attached to a protein. In contrast, in the 
process of poly‐ubiquitination, several Ubs are transferred to the substrate. The different forms of poly‐
ubiquitination differ in the way the individual ubiquitin molecules are linked together. Ubiquitin has 
seven lysines and all of them can be used for linkage. The K48‐linked‐poly‐ubiquitination is a classical 
signal for proteasomal degradation, where four Ubs is the minimum amount required for efficient 
degradation. (Thrower et al., 2000). K63‐linked‐poly‐ubiquitination is often a signal for endocytosis 
(Galan and Haguenauer‐Tsapis, 1997). There are also more complex forms of poly‐ubiquitination known 
where the association between the Ub molecules is heterogenous, although they are not well 
characterized (Komander and Rape, 2012). The post‐translational modification of ubiquitination is 
carried out by an enzymatic cascade starting with the activation of Ub by an E1 enzyme in an ATP‐
dependent manner (Hershko and Ciechanover, 1998, Berndsen and Wolberger, 2014). In a next step, Ub 
is transferred from E1 to a cysteine residue of an E2 enzyme (Hershko and Ciechanover, 1998). The active 
E2 enzyme is then recruited to a large E3 ubiquitin ligase complex, which finally modifies certain lysine 
residues or the N‐termini of specific substrates (Berndsen and Wolberger, 2014). 
 
1.1.2 Cullin-RING E3 ubiquitination ligases 
There are three different classes of E3 ligases (E3s): the RING, HECT and RBR protein families (reviewed 
in Berndsen and Wolberger, 2014). Together, there are more than 600 different E3 ligases present in the 
human genome (Li et al., 2008). The Cullin protein family (Cullin 1, Cullin 2, Cullin 3, Cullin 4a, Cullin 4b, 
Cullin 5 and Cullin 7 in mammals) is part of the RING E3 ligase family and it is the most prevalent class of 
E3s (Metzger et al., 2014). An additional but rather atypical member of the Cullin family is the p53‐
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associated parkin‐like cytoplasmic protein (Parc) (Marín, 2009). The Cullin family was initially discovered 
in C. elegans, with Cullin 1 being a negative regulator of the cell‐cycle and its null‐mutation leading to 
hyperplasia in early development (Kipreos et al., 1996). An early study of CDC53/Cullin 1 in yeast 
demonstrated its role in ubiquitination and protein degradation (Mathias et al., 1996). 
In the modular Cullin‐RING E3 ligase (CRL) complexes, the Cullin proteins themselves act as molecular 
scaffolds for the assembly of these complexes, where their main function is to join together the 
ubiquitination target substrate and the activated E2 enzyme into one protein complex (Furukawa et al., 
2002). The E2 enzyme provides the Ub moiety to be transferred to the ubiquitination substrate. The 
Cullin proteins all share a conserved Cullin homology domain at the C‐terminus. This domain is required 
for the recruitment of the RING finger proteins Rbx1 and Rbx2, which act as adaptors for the E2 enzyme 
(Furukawa et al., 2002). To recognize their specific substrates, CRLs rely on specific substrate adaptor 
proteins. The general molecular organization is conserved in all Cullin E3 ligases, as the substrate 
adaptors associate with the N‐termini of Cullin scaffolds and RING finger proteins interact with their C‐
termini (Fig. 3). 
 
Figure 3. The molecular organization of CRL1 and CRL3 complexes.  
The Cullin scaffold proteins arrange the E3 ligase complexes. The substrate recognition module binds to 
the N‐termini of the Cullin scaffold and the RING finger protein Rbx1 recruits the E2 enzyme to their C‐
termini. The major difference between CRL1 and CRL3 complexes is the way of substrate recognition. 
CRL1 targets substrates by Skp1 and one of many F‐box proteins, while CRL3 target their substrate by 
means of a single BTB substrate adaptor. NEDD8 acts as a regulator for both CRL complexes. 
 
Cullin 3‐RING E3 ubiquitin ligases (CRL3) differ from the other Cullin‐RING E3 ligases in their way of 
substrate recognition (Furukawa et al., 2003). In Cullin 1‐RING E3 ubiquitin ligases (CRL1), the substrate 
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specificity is regulated by two proteins, the Skp1 adaptor as well as one of many F‐Box proteins, which 
serve as the actual substrate recognition proteins (Skaar et al., 2013). In CRL3 on the other hand, the 
substrate specificity is provided by one single substrate adaptor protein, which belongs to the BTB 
protein superfamily (Furukawa et al., 2003, Sarikas et al., 2011). Figure 3 illustrates the general molecular 
organization of CRL1 and CRL3. 
 
1.1.3 Regulation of Cullin-RING E3 ligases 
The E3 ligase activity of CRL complexes themselves is regulated by an ubiquitin‐like modifier called 
NEDD8, the respective posttranslational modification is called neddylation (Osaka et al., 1998, Ohh et al., 
2002). Similar to ubiquitination, neddylation is governed by an E1/E2/E3 enzymatic cascade (Osaka et al., 
1998). In CRLs, the Cullin scaffolds are neddylated at a conserved lysine in the Cullin homology domain 
which promotes the ubiquitination activity of the CRLs by a structural reorganization. Deneddylation and 
inactivation of CRLs, is mediated by the COP9 signalosome (CSN). Another important regulator of CRLs is 
Cullin‐associated NEDD8‐dissociated protein 1 (CAND1). CAND1 molecules bind to unneddylated Cullins 
and inhibit E3 ligase activity (Zheng et al., 2002). Neddylation of Cullins displaces CAND1 from the 
complex (Liu et al., 2002). The precise mechanisms and functions of CAND1 are still debated (Sarikas et 
al., 2011). 
 
1.1.4 Substrate adaptors of Cullin 3-RING E3 ligases 
Several protein families including the KCTD proteins contain a BTB structural domain (Genschik et al., 
2013, Skoblov et al., 2013). About 180 different BTB proteins are known in humans, although not all of 
them may form E3 ligases (Stogios et al., 2005).  
In contrast to CRL1, in CRL3s the substrate specificity is mediated by one single BTB protein (Furukawa et 
al., 2003). One of the best characterized BTB substrate adaptors is the SPOP protein. A high‐resolution 
crystal structure of the Cul3‐SPOP complex was solved (Errington et al., 2012). For the Cullin 3‐SPOP 
interaction, the N‐terminal alpha helices H2 and H5 of Cullin 3 were shown to be crucial (Errington et al., 
2012). Similar to SPOP, the BTB substrate adaptor KLHL11 also interacts with alpha helices H2 and H5 of 
Cul3 (Canning et al., 2013). 
Conceptually, the KCTDs are thought to bind to the Cullin 3 scaffold through their BTB domain (within T1 
domain) and to their specific ubiquitination substrates through their more variable C‐term (Skoblov et 
al., 2013). This overall model was confirmed for several KCTD members, such as KCTD5, KCTD6, KCTD7, 
KCTD21 (Bayón et al., 2008, Azizieh et al., 2011, De Smaele et al., 2011). Recently, Smaldone and 
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coauthors showed that not all KCTD proteins associate with Cullin 3, as KCTD12 and KCTD15 were shown 
to lack the Cullin 3‐binding property (Smaldone et al., 2015). This inability to interact with Cullin 3 likely 
stems from a structural alteration of the BTB domain of KCTD12 compared to members of other KCTD 
subfamilies. On the basis of their Cul3‐binding experiments with the isolated BTB domain of KCTD12, 
they assumed that the other members of the subclade of KCTD12, namely KCTD8 and KCTD16, are also 
deficient in binding to Cul3 (Smaldone et al., 2015). Apart from the mentioned study, the subfamily of 
the GABAB‐associated KCTDs is not studied with regard to ubiquitination signaling via Cullin 3 (Skoblov et 
al., 2013). 
 
1.1.5 Ubiquitination and degradation of GABAB receptors 
Like other GPCRs, the plasma membrane levels of GABAB receptors are regulated by ubiquitination and 
degradation processes. Several lysines on both GABAB1 and GABAB2 were found to be ubiquitinated in 
vivo (Na et al., 2012). According to Lahaie et al., the residues K887, K893, K900 and K905 are potential 
ubiquitination sites on GABAB1b, while the same is true for residues K767 and K771 on GABAB2 (Lahaie et 
al., 2016). 
At the beginning of its life cycle, GABAB receptor is a substrate for the ER‐associated degradation (ERAD) 
system, probably as part of the quality control system in the ER. In the ERAD pathway, substrates are 
ubiquitinated by specific E3 ligases while they reside in the ER and get degraded by the proteasome 
afterwards. The ERAD E3 ligase Hrd1 was shown to ubiquitinate the GABAB2 subunit at lysines 767/771, 
targeting GABAB2 to the proteasomal degradation pathway (Zemoura et al., 2013). Consequentially, 
surface levels of GABAB are influenced by this mechanism, as blockade of the proteasome or ERAD leads 
to increased GABAB on the plasma membrane (Zemoura et al., 2013). 
At the end of the life cycle of a GPCR, the receptors are typically endocytosed from the plasma 
membrane and either recycled back to the membrane or degraded in lysosomes. In many cases, receptor 
internalization is agonist‐dependent. The GABAB receptor is an exception in this regard, as GABAB 
receptors do not undergo classical agonist‐dependent internalization by β arrestin recruitment (Raveh et 
al., 2015). It is known that GABAB is internalized in a rapid constitutive manner (Grampp et al., 2008). 
Glutamate signaling also leads to endocytosis of GABAB receptors (Guetg et al., 2010, Maier et al., 2010). 
Furthermore, coordinated action of NSF and phosphorylation by PKC was shown to induce GABAB 
receptor internalization (Pontier et al., 2006). 
Recently, overexpression of ubiquitin specific protease 14 (USP14) was shown to lead to decreased 
ubiquitination of GABAB but to increased degradation of GABAB (Lahaie et al., 2016). This USP14‐
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promoted degradation of GABAB was lysosomal‐dependent. Interestingly, the deubiquitination activity of 
USP14 was shown to be independent of its degradation of GABAB, suggesting that USP14‐
deubiquitination might play a role in the recycling of ubiquitin. Lahaie et al. propose that GABAB 
receptors are ubiquitinated in a PKC‐dependent manner at the plasma membrane, which leads to the 
USP14‐mediated degradation after endocytosis. 
 
In this chapter, I describe the unexpected finding that KCTD16 and KCTD8 are actually novel protein 
interaction partners of Cullin 3. Furthermore, I show that they bind to Cul3 by their C‐terminal H2 
domains and not by their BTB domains. I also demonstrate that KCTD16 is recruiting Cul3 to the GABAB 
receptor. 
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1.2 Materials and Methods 
Expression plasmids 
The pCI‐Myc‐KCTD constructs (myc‐KCTD12, myc‐KCTD16, myc‐KCTD8, myc‐KCTD16T1‐12H1, myc‐
KCTD16ΔH2, myc‐KCTD16H2, myc‐KCTD8ΔH2, myc‐KCTD16H1H2, myc‐KCTD12‐16H2, myc‐KCTD12‐16H2 
Δ60) were described earlier (Seddik et al., 2012).  
For pCI‐Myc‐KCTD12‐16H2 Δ39, a stop codon was inserted after residue Leu388. 
The pCI‐Cullin 3‐Flag was generated by overlap extension PCR and subsequent subcloning into the pCI 
vector (Promega, WI, US), so that the Flag tag directly follows after the human Cullin 3 coding sequence. 
The pCDNA3‐myc‐Cul3 plasmid served as a template for this PCR. The pCI‐Cullin 1–Flag plasmid was 
generated in the same way as the pCI‐Cullin 3‐Flag plasmid, using the pCDNA3‐myc‐Cul1 plasmid as a 
template. The two plasmids pcDNA3‐myc3‐Cul1 (Addgene plasmid #19896) and pcDNA3‐myc‐CUL3 
(Addgene plasmid #19893) were gifts from Yue Xiong (Ohta et al., 1999). 
To generate pCI‐Rluc‐Cul3 with overlap extension PCR, the Rluc gene was cloned directly in front of 
human Cullin 3 without a linker peptide. For pCI‐KCTD16‐Venus and pCI‐KCTD8‐Venus, the linker peptide 
DIGGGSGGGGS followed by the Venus tag were fused to the C‐termini of KCTD16 and KCTD8. The pEGFP‐
Venus‐KCTD16 and pEGFP‐Venus‐KCTD8 plasmids were made by changing GFP to Venus followed by the 
EcoRI restriction site in front of the N‐termini of KCTD16 and KCTD8. 
 
Cell culture 
COS‐1 and HEK293T cells were maintained in DMEM + 10% FCS in a cell culture incubator set to 37°C 
with 5% CO2. Cells were split twice a week. Cell transfection was done using Lipofectamine 2000 (Life 
Technologies) according to the manufacturer's protocol. DNA amounts were equalized by empty pCI 
Vector DNA (Promega, WI, US). 
 
Co-immunoprecipitation and Western Blot 
Between 24 and 48 hours after transfection, COS‐1 cells were washed in ice‐cold PBS and lysed in NETN 
buffer (100mM NaCl, 20 mM Tris, 1mm EDTA, 0.5% NP40, pH 7.4) supplemented with EDTA‐free 
cOmplete protease inhibitors (Roche). Lysates were then used for Western Blot (Input) or 
immunoprecipitations. Immunoprecipitations were done using magnetic Protein G beads (Dynabeads, 
10004D, Life Technologies) according to the manufacturer’s protocol. Briefly, lysates and antibody 
coupled to beads were incubated for 10min at room temperature, beads were washed four times with 
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NETN buffer and eluted with 1x Lämmli Buffer. Input and IPs were resolved with standard SDS‐PAGE on 
8‐12% acrylamide gels. 
 
Co-immunoprecipitation using mouse brain tissue 
For the immunoprecipitation experiment with mouse brain lysates, full brains from 4‐week old mice 
were homogenized in ice‐cold NETN buffer, using a glass‐teflon homogenizer (30 strokes). Brain 
homogenates were centrifuged at 15’000g for 10min at 4°C. Proteins were immunoprecipitated with 
antibodies coupled to protein G‐agarose (Roche Applied Science) and NETN buffer was used as a washing 
buffer.  
 
BRET experiments 
HEK293T cells were transiently transfected with indicated plasmids by Lipofectamine 2000 transfection. 
Five hours later, cells were trypsinized and plated into 96‐wellplates (Greiner Bio‐One, Kremsmünster, 
Austria). One day later, the cells were washed with PBS with MgCl2 and CaCl2 (Sigma‐Aldrich, D8862) and 
incubated with the coelenterazine substrate (NanoLight Technologies, AZ, US) diluted in PBS with MgCl2 
and CaCl2. BRET signals were measured with an Infinite® F500 Microplate Reader (Tecan, Männedorf, 
Switzerland).  
 
Immunostainings of hippocampal neurons 
Dissociated hippocampal cultures of WT mice (DIV14) were fixed by incubation with 4% PFA + 4% 
sucrose in PBS for 10min. Permeabilization was performed with 0.25% Triton‐X in PBS with MgCl2 and 
CaCl2 (Sigma‐Aldrich, D8862) for 10min at room temperature. PBS with MgCl2 and CaCl2 was used for the 
washing steps. Unspecific binding sites were blocked by incubation with 5% BSA in PBS with MgCl2 and 
CaCl2 for one hour at room temperature. Primary antibodies were incubated in blocking solution for one 
hour at room temperature. Secondary antibodies were incubated in blocking solution for 45min at room 
temperature. Finally, the stained samples were mounted using Fluoromount (Sigma‐Aldrich, F4680). 
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Primary antibodies used for IPs and Western Blots 
 
Name  Host  Company  Product Nr. WB  IP 
Anti‐Flag M2 Mouse  Sigma   F1804  ‐  2µl 
Anti‐Flag Rabbit  Sigma   F7425  1:1000  ‐ 
Anti‐myc 9e10 Mouse  Santa Cruz  sc‐40  ‐  5µl 
Anti‐myc Rabbit  Sigma   C3956  1:1000  ‐ 
Anti‐Cul3 Rabbit  Abcam   ab75851 1:1000  2µl 
Anti‐KCTD16 Rabbit  Metz et al., 2011 ‐  1:1000  ‐ 
Anti‐KCTD16 Guinea pig Metz et al., 2011 ‐  1:1000  4µl 
Anti‐GB2 Rabbit  Alomone  AGB‐002 1:1000  ‐ 
Anti‐K48‐Ub Rabbit  Millipore  05‐1307 1:1000  ‐ 
 
Antibodies used for immunostainings of hippocampal neurons 
Name   Host  Company  Product Nr. Dilution   
Anti‐KCTD16  Rabbit  Metz et al., 2011 ‐  1:250   
Anti‐Cullin 3  Mouse  Sigma‐Aldrich  SAB4200180 1:250   
Anti‐MAP2  Chicken  Abcam   ab5292  1:5000  
Anti‐Rabbit Alexa 488 Donkey  Life Technologies A21206  1:1000 
Anti‐Mouse Alexa 555 Donkey  Life Technologies A31570  1:1000 
Anti‐Chicken Alexa 647 Donkey  Millipore  AP194SA6 1:1000 
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1.3 Results 
1.3.1 KCTD16 and KCTD8 but not KCTD12 bind to the Cullin 3-RING E3 ubiquitin ligase 
Several members of the KCTD protein family are known to have a role as substrate adaptors of Cullin 3‐
RING E3 ubiquitin ligases, regulating diverse biological processes (Skoblov et al., 2013). To test whether 
KCTD12, KCTD16 and KCTD8 also associate with Cullin 3, co‐immunoprecipitation experiments using 
transfected COS‐1 cells were conducted. Figure 4A shows that both KCTD16 and KCTD8 bind to Cullin 3, 
while KCTD12 does not. Of note, KCTD8 displayed a weaker affinity for Cullin 3 when compared to 
KCTD16. 
KCTD16 and KCTD8 have different expression patterns in the mouse brain, with KCTD16 being relatively 
abundant compared to KCTD8 (Metz et al., 2011). Notably, KCTD16 is strongly expressed in hippocampal 
neurons, while KCTD8 expression in the hippocampus is very weak (Metz et al., 2011). To study the 
endogenous expression patterns of KCTD16 and Cullin 3 in hippocampal neurons, I carried out 
immunostainings of dissociated hippocampal neurons of WT mice at DIV14. As shown in Fig. 4B, both 
KCTD16 and Cullin 3 are endogenously co‐expressed in hippocampal neurons. Of note, both proteins are 
well expressed in the dendritic compartment (stained with the marker MAP2), as shown in the insets of 
Fig. 4B. This endogenous co‐expression of KCTD16 and Cullin 3 in hippocampal neurons supports a 
possible biochemical association in vivo.  
Finally, in order to check whether the KCTD16 interaction with Cullin 3 can also be demonstrated in 
neurons, I performed co‐immunoprecipitation experiments with whole brain lysates from WT or KCTD16 
KO mice. As shown in Figure 4C, the KCTD16‐Cul3 interaction was also observed in mouse brain lysates in 
both directions. Therefore, the protein‐protein interaction previously obtained with the recombinant 
assay using overexpression (in Fig. 4A) was confirmed using mouse brain tissue. 
In summary, KCTD16 and KCTD8 were found to be novel protein‐protein interaction partners of Cullin 3, 
whereas KCTD12 is not a direct interactor of Cullin 3‐RING E3 ubiquitin ligases. For the more widely 
expressed KCTD16, this novel association with Cullin 3 was also confirmed in mouse brain tissue. 
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Figure 4. KCTD16 and KCTD8 but not KCTD12 bind to the Cullin 3-RING E3 ubiquitin ligase.  
(A) Co‐immunoprecipitation experiment using COS‐1 cells transfected with Cullin 3‐Flag and myc‐
KCTD16, myc‐KCTD8 or myc‐KCTD12. Cullin 3 was immunoprecipitated and detected with anti‐Flag 
antibodies, while KCTDs were detected with anti‐myc antibodies. KCTD16 and KCTD8 but not KCTD12 co‐
precipitate with Cullin 3. (B) Immunostainings of hippocampal neurons. KCTD16 and Cullin 3 are 
endogenously co‐expressed in hippocampal neurons, MAP2 is a dendritic marker. Insets show a proximal 
dendrite of the neuron. (C) Co‐immunoprecipitation experiment with mouse brain lysates of WT and 
KCTD16 KO mice. Endogenous Cullin 3 and KCTD16 were immunoprecipitated and detected using anti‐
KCTD16 and anti‐Cullin 3 antibodies. KCTD16 is binding to Cullin 3 in mouse brain lysates. 
 
  
A 
C 
KCTD16 
KCTD12 
KCTD8 
+     +     + 
+     -     - 
-     +     - 
-     -     + 
Cullin 3-Flag           
Myc-KCTD16          
Myc-KCTD12          
Myc-KCTD8 
Cullin 3 
IP: Flag Input 
+     +     + 
+     -     - 
-     +     - 
-     -     + 
WT KCTD16 
          KO      
Brain lysate IP: Cul3 
WT KCTD16 
          KO      
KCTD16 
Cullin 3 
IP: KCTD16 
WT KCTD16 
          KO      
KCTD16 Cullin 3 MAP2 Merge 
B 
Chapter 1: Results 
 
‐ 31 ‐ 
1.3.2 The H2 domains of KCTD16 and KCTD8 are important for Cullin 3-binding 
Generally, substrate adaptors for CRL3 complexes bind to the Cullin 3 scaffolds through their BTB 
domains (Furukawa et al., 2003, Genschik et al., 2013). The KCTDs also possess BTB domains, which are 
located in their T1 domains. To study whether the BTB domain is required for KCTD16‐binding to Cullin 3, 
I tested different constructs of KCTD16 and KCTD12 by performing co‐IP experiments using transfected 
COS‐1 cells (Fig. 5A). Identical to the results in Fig. 4, full length KCTD16 binds to Cullin 3, while KCTD12 
does not. Unexpectedly, both constructs containing the T1 domain of KCTD16 (16T1‐12H1 and 16ΔH2) 
do not bind to Cullin 3, suggesting a non‐conventional BTB‐independent binding of KCTD16 to Cullin 3. 
Deletion of the KCTD16 H2 domain abolished Cullin 3‐binding (16ΔH2), suggesting that the H2 domain is 
required for this protein interaction. Strikingly, attaching the H2 domain of KCTD16 to KCTD12 renders 
this construct (12‐16H2) capable of Cullin 3‐binding, confirming the necessity of the H2 domain for the 
interaction with Cullin 3. Next, I wanted to test whether the H2 domain of KCTD8 is also relevant for 
Cullin 3‐binding. By performing co‐IP experiments, I found that the H2 domain of KCTD8 was also 
necessary for the association with Cullin 3 (Fig. 5B), as binding was abolished when the H2 domain was 
deleted (8ΔH2). As the H2 domains of both KCTD16 and KCTD8 are required for Cullin 3‐binding, I wanted 
to test whether the isolated H2 domain of KCTD16 is not only necessary but also sufficient for this 
interaction. I found that the isolated H2 domain of KCTD16 (16H2 construct) was not sufficient to bind to 
Cullin 3 (Fig. 5C), in contrast to the 16H1H2 construct. This 16H1H2 construct consists of both H1 and H2 
domains of KCTD16 and represents the minimal Cullin 3‐binding construct identified in this experiment. 
Potentially, the low expression level of 16H2 or a problem with proper folding might explain the inability 
of 16H2 to interact with Cullin 3. Altogether, I found that the BTB‐containing T1 domains are not 
required for the Cullin 3 association, while the H2 domains of KCTD16 and KCTD8 play an important role 
in these protein‐protein interactions, describing for the first time an interaction between KCTDs and 
Cullin 3 that is not BTB domain‐dependent. 
The importance of the H2 domain for Cullin 3‐binding was demonstrated in Fig. 5A‐C. In order to define 
the binding site more closely, two C‐terminal deletion mutants of the H2 domain were tested. These 
constructs were made on the background of the H2 domain of KCTD16 fused to KCTD12. The last 39 or 
60 amino acids of the H2 domain were deleted. Co‐immunoprecipitations show that both constructs (12‐
16H2Δ60 and 12‐16H2Δ39) were unable to bind to Cullin 3 (Fig. 5D). These results confirm the 
requirement of the H2 domain and further suggest that the C‐terminal part of the H2 domain is 
necessary. A summary of the used constructs and their ability of Cullin 3‐binding is given in Fig. 5E. 
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Figure 5. The H2 domains of KCTD16 and KCTD8 are required for binding to Cullin 3. 
Cell lysates and co‐immunoprecipitations of COS‐1 cells transfected with Cullin 3‐Flag and various KCTD 
constructs. Immunoprecipitations were done with indicated antibodies. KCTDs and Cullin 3 were 
detected using anti‐myc and anti‐Flag antibodies. (A) Domain mapping of the Cullin 3‐binding site on 
KCTD16 using full length and chimeric constructs of KCTD16 and KCTD12. Full length KCTD16 binds to 
Cullin 3, KCTD12 serves as a negative control. Both constructs containing the T1 domain of KCTD16 
(16T1‐12H1 and 16ΔH2) do not bind to Cullin 3, whereas attaching the H2 domain of KCTD16 to KCTD12 
transfers Cullin 3‐binding to KCTD12. (B) Deletion of the H2 domains of KCTD16 and KCTD8 abolishes 
binding to Cullin 3 demonstrating the importance of the H2 domains for Cullin 3‐binding. (C) The isolated 
H2 domain of KCTD16 (16H2) is not sufficient for binding to Cullin 3, in contrast to the combination of 
the H1 and H2 domains of KCTD16 (16H1H2) or full length KCTD16. Asterisk indicates a nonspecific band 
in the immunoprecipitations. (D) C‐terminal 39 or 60 amino acids of the H2 domain were deleted on the 
background of the 12‐16H2 construct (12‐16H2Δ39 and 12‐16H2Δ60). Both C‐terminal H2 deletion 
constructs result in loss of binding to Cullin 3. (E) Overview of the protein domain structure of the used 
KCTD constructs and summary of their ability to associate with Cullin 3.  
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1.3.3 The N-terminus of Cullin 3 is sufficient for binding to KCTD16 
In general, substrate adaptors of Cullin 3 are thought to bind to the N‐terminal part of Cullin 3, in order 
to sterically position the substrate for ubiquitination by the E2 ubiquitination enzyme, which is linked to 
the C‐terminus of the Cullin 3 (Furukawa et al., 2002, Furukawa et al., 2003). To test the hypothesis that 
KCTD16 similarly binds to the N‐terminus of Cullin 3, two deletion constructs of Cullin 3 were made: Cul3 
N223 consists of amino acids 1‐223 of Cullin 3, while in the Cul 3 Δ218 construct amino acids 1‐218 are 
deleted (Fig. 6A). These constructs together with full‐length Cullin 3 were then assayed 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. The N-terminus of Cullin 3 is sufficient for binding to KCTD16.  
(A) Schematic illustration of the Cullin 3 constructs used in the co‐immunoprecipitation experiments. To 
study the importance of the N‐terminus of Cullin 3 for KCTD16‐binding, I used a full length Cul3‐Flag, a 
Cul3 construct composed of the N‐terminal 223 amino acids (Cul3 N223‐Flag) and a Cul3 construct 
consisting of the C‐terminal amino acids 219‐768 (Cul3 Δ218‐Flag). (B) Co‐immunoprecipitation 
experiment using transfected COS‐1 cells. Cells were transfected with myc‐KCTD16 together with Cul3‐
Flag, Cul3 N223‐Flag or Cul3 Δ218‐Flag. The Cullin 3 constructs were immunoprecipitated by using their 
Flag tag. Western Blot detection of the samples was done using anti‐myc and anti‐Flag antibodies.  
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for KCTD16‐binding by performing co‐immunoprecipitation experiments with transfected COS‐1 cells 
(Fig. 6B). These co‐IP experiments show that the N‐terminus of Cullin 3 (Cul3 N223) is sufficient to 
interact with KCTD16. The strength of interaction is similar to full length Cullin 3. In contrast, KCTD16 
binding for Cul3 Δ218 was significantly diminished to about 30% of Cul3 full length control, 
demonstrating that deletion of the N‐terminus dramatically weakens the binding to KCTD16. The residual 
KCTD16‐binding of Cul3 Δ218 could potentially be explained by association of this construct with 
endogenous Cullin 3, as Cullin 3 is endogenously expressed in COS‐1 cells. Overall, these results are in 
agreement with the proposed binding of KCTD16 to the N‐terminus of Cullin 3, similar to what was 
observed for other BTB protein family members (Genschik et al., 2013). 
1.3.4 BRET studies confirm interactions of KCTD16 and KCTD8 with the N-terminus of Cullin 3 
Figure 7. Bioluminescence resonance energy transfer (BRET) experiments to measure protein-protein 
interactions in living cells. Two fusion‐proteins are co‐expressed in cells. Protein A is tagged with Rluc 
and protein B is tagged with YFP. Blue light (475nm) is emitted when the cells are incubated with the 
substrate coelenterazine, being the substrate for a bioluminescent reaction catalyzed by the Rluc 
enzyme. Upon interaction of proteins A and B, the distance between Rluc and YFP is permissive for BRET. 
A distance of less than 10nm is considered to be required for BRET. Energy is transferred from the Rluc 
donor to the YFP acceptor, which emits yellow light (527nm). BRET efficiency is strongly dependent on 
the distance between donor and acceptor. 
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The previous co‐IP experiments led me to a model where the C‐termini of KCTD16 or KCTD8 bind to the 
N‐terminus of Cullin 3. At this point, I decided to confirm this interaction model by a different 
experimental technique. Another method often used to study protein‐protein interactions is based on 
the principle of bioluminescence resonance energy transfer (BRET). The general mechanism for BRET 
experiments is shown in Fig. 7.  
 
Figure 8. BRET measurements confirm the C-terminal binding of KCTD16 and KCTD8 to the N-terminus 
of Cullin 3 in living cells. (A) Experimental setup of the Cullin 3‐KCTD16 BRET assay. If KCTD16 and KCTD8 
bind to Cullin 3 as proposed, it is expected that the N‐terminally Venus‐tagged KCTD proteins induce 
weaker BRET than their C‐terminally‐tagged counterparts. (B) To generate the BRET saturation curves, 
increasing amounts of the Venus‐tagged KCTD constructs were co‐expressed together with constant 
amounts of Rluc‐Cullin 3 in HEK293 cells. The result confirms the proposed binding of the N‐terminus of 
Cullin 3 to the C‐termini of KCTD16 and KCTD8. 
 
The rationale of my BRET experiments is outlined in Fig. 8A. Venus tags were attached to KCTD16/8, at 
their C‐termini or their N‐termini and co‐expressed with Cullin 3 with a Rluc tag attached to its N‐
terminus in HEK 293 cells. BRET saturation curves (Fig. 8B) show that the highest BRET signals, meaning 
closer physical distance, were obtained when the Venus tag was attached at the C‐termini of KCTD16 or 
KCTD8, compared to the Venus tag at the N‐termini. This result confirms my previous observation that 
the binding site for Cullin 3 in KCTD8/16 is located at the C‐terminus which contains the H2 domain. 
Furthermore, this is clear evidence that the KCTD16/8‐Cul3 interactions also happen in living cells.  
A B 
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1.3.5 KCTD16 is able to recruit Cullin 3 to the GABAB receptor complex 
As KCTD16 and KCTD8 are described as auxiliary subunits of GABAB receptors (Schwenk et al., 2010, 
Gassmann and Bettler, 2012), the question arose whether there is recruitment of the CRL3 complex to 
the GABAB receptor by these KCTDs acting as molecular linkers (Figure 9B). To test this hypothesis, I 
performed co‐IP experiments using transfected COS‐1 cells. The GABAB‐associated KCTDs bind to the 
GABAB2 subunit (Schwenk et al., 2010), therefore I co‐expressed Cullin 3 and GABAB2 together with  
 
Figure 9. KCTD16 but not KCTD8 recruits Cullin 3 to the GABAB receptor complex.  
(A) Co‐immunoprecipitation experiment using transfected COS‐1 cells showing the ability of KCTD16 to 
link Cullin 3 to the GABAB2 subunit. Cullin 3 was immunoprecipitated with anti‐Flag antibodies followed 
by Western Blot detection with anti‐Flag, anti‐myc and anti‐GABAB2 antibodies. Asterisk indicates a non‐
specific band in the inputs. Expectedly, no Cul3‐recruitment to GABAB was observed for the negative 
controls 16ΔH2 and GABAB2 Y902A. Surprisingly, KCTD8 was unable to bridge GABAB and Cul3. (B) Model 
showing the recruitment of CRL3 to the GABAB receptor via KCTD16. 
 
KCTD16 or KCTD8. Next, Cullin 3 was immunoprecipitated using its Flag‐tag and the indirect co‐IP of 
GABAB2 was assessed. KCTD16ΔH2 and the KCTD‐binding deficient mutant GABAB2 Y902A were used as 
negative controls. These co‐IP experiments demonstrated that KCTD16 is able to link Cullin 3 to the 
GABAB2 subunit (Fig. 9A). On the other hand, KCTD8 could not be demonstrated to recruit the GABAB 
receptor to Cullin 3 complexes. A possible reason might be the weaker affinity of KCTD8 for Cullin 3 
compared to KCTD16, which renders it more difficult to show an indirect protein interaction with 
GABAB2. As expected, neither the KCTD16ΔH2 nor the GABAB2 Y902A conditions were showing CRL3 
recruitment to GABAB receptors. 
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1.3.6 KCTD16 co-expression does not constitutively down-regulate GABAB receptors 
In the previous experiment, I demonstrated that KCTD16 is able to link Cullin 3 to GABAB receptors. This 
posed the obvious question whether the GABAB receptor itself is a target for ubiquitination and 
degradation by KCTD16‐CRL3 complexes. To test whether co‐expression of KCTD16 has a direct effect on 
GABAB receptor total levels, COS‐1 cells were transfected with the two principal subunits GABAB1b and 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Co-expression of KCTD16 with GABAB receptors does not down-regulate GABAB receptor 
total levels in transfected COS-1 cells. In order to test for a direct effect of KCTD16 on GABAB receptor 
total levels, GABAB receptors were co‐transfected with or without KCTD16. The co‐transfection with 
KCTD16ΔH2 served as a negative control. The proteasome inhibitor MG‐132 (10µM) or the lysosomal 
inhibitor chloroquine (100µM) was incubated to dissect a possible effect regarding the route of 
degradation. However, co‐expression of KCTD16 does not down‐regulate GABAB receptor total levels. 
 
GABAB2 together with or without KCTD16. KCTD16ΔH2 served as a negative control. Of note, Cullin 3 is 
endogenously expressed, thus functional KCTD16‐CRL3 complexes are expected to form in these 
transfected cells and overexpression of CRL substrate adaptors alone is usually enough to produce 
pronounced effects on protein levels of their ubiquitination substrate, e.g. overexpression of KCTD21 
and KCTD6 drastically decrease their substrate Histone deacetylase 1 (HDAC1) (De Smaele et al., 2011). 
To dissect a possible degradation effect on protein levels, the proteasomal inhibitor MG132 (10µM, 
Sigma Aldrich, M7449) and the lysosomal inhibitor chloroquine (100µM, Tocris, 4109) were incubated 
overnight in the indicated samples. It turned out that co‐expression of KCTD16 does not down‐regulate 
total protein levels of both principal GABAB receptor subunits under these conditions (Fig. 10). This 
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argues against a hypothesized constitutive ubiquitination and degradation of GABAB receptors by 
KCTD16‐CRL3 complexes. 
 
In conclusion, I found that GABAB receptor‐associated KCTD16 and KCTD8 are novel Cullin 3 interaction 
partners, in contrast to KCTD12. Furthermore, the KCTD16 and KCTD8 interactions with Cullin 3 are non‐
conventional and BTB‐independent, as they rely on their H2 domains. KCTD16 was also shown to recruit 
the CRL3 complex to the GABAB receptor. 
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1.4 Discussion 
Many KCTDs have been reported to be interactors of Cullin 3‐RING E3 ubiquitin ligases (reviewed in 
Skoblov et al., 2013). In these large multi‐subunit E3 complexes, BTB proteins such as the KCTDs are 
thought to function as the substrate adaptors for these complexes (Furukawa et al., 2003). One last 
subclade of the KCTD family is mostly unstudied in this regard (Skoblov et al., 2013). This subfamily 
encompasses KCTD12, KCTD16 and KCTD8, all of them are known to be auxiliary subunits of GABAB 
receptors, where they specifically modulate receptor responses (Schwenk et al., 2010). In this chapter, I 
performed a systematic Cullin 3‐binding assay of this unstudied subfamily and I concluded that KCTD16 
and KCTD8 are indeed interacting with Cullin 3 (Fig. 4A). These interactions were observed in 
recombinant system, in live cells as well as in brain tissue. 
Interestingly, I found that KCTD16 and KCTD8 bind Cullin 3 not through the canonical Cullin 3‐interacting 
BTB domains, but rather through their C‐terminal H2 domains. As shown in Figure 5, I found that H2 
domain deletion constructs of KCTD16 or KCTD8 as well as full length KCTD12, which lacks an H2 domain, 
are unable to bind to Cullin 3. In contrast, I demonstrated that full‐length KCTD16 and KCTD8 show the 
unexpected property of Cullin 3‐binding and strikingly, this trait can be transferred to KCTD12, when the 
H2 domain of KCTD16 is fused to KCTD12 (Fig. 5A). Of note, the isolated H2 domain was unable to 
interact with Cullin 3, therefore the H2 domain is necessary but not sufficient for this interaction. I 
speculate that the low expression of this construct and possibly improper folding of the isolated H2 
domain explain this result. The minimum Cullin 3‐binding construct of KCTD16 was found to be 16H1H2, 
further corroborating that the T1 domain, which contains the BTB domain, is completely dispensable for 
this protein interaction. 
In this thesis, I described a new H2 domain‐dependent mechanism of KCTD16 and KCTD8 interaction 
with Cullin 3, opening up the possibility that not just BTB‐domain containing proteins could be adaptors 
for CRL3 complexes. This possibility would further expand the number of potential CRL3 substrate 
adaptors. This atypical binding pattern explains two important points: First, it directly follows why only 
KCTD16 and KCTD8 are interacting with Cullin 3 (as both contain an H2 domain), but KCTD12 does not (as 
KCTD12 lacks the necessary H2 domain). Second, it fully explains Smaldone and coauthors observations. 
This group proposed that this KCTD subfamily is unable to interact with Cullin 3, based on their Cullin 3‐
interaction experiments with the purified BTB domain of KCTD12 (Smaldone et al., 2015). In this work, I 
used full‐length KCTD proteins to assay for a Cullin 3‐interaction rather than purified BTB domains, 
allowing us to find this new H2 domain‐based binding mechanism. Also, I confirmed their previous 
observation that KCTD12 is unable to bind to Cullin 3 (Smaldone et al, 2015). I know now that the reason 
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of this result is that KCTD12 lacks the H2 domain and that its BTB domain is also incapable of binding. 
The inability to directly interact with Cullin 3 renders KCTD12 an exception in its subclade of the KCTD 
family. The fact that KCTD12 was found to be associated with Cullin 3 in a proteomic study (Bennett et 
al., 2010) might be explained by its heteromerization with either KCTD16 or KCTD8 (T. Fritzius, personal 
communication). For unknown reasons, KCTD16 and KCTD8 were not found as Cullin 3 interactors in the 
mentioned proteomic study (Bennett et al., 2010). 
Classically, BTB proteins are thought to be the molecular substrate adaptors for Cullin 3‐RING E3 
ubiquitination ligases (Furukawa et al., 2003). In analogy to other BTB proteins, it is conceivable that 
KCTD16 and KCTD8 are functioning as substrate adaptors. The finding that KCTD16 associates with the N‐
terminus of Cullin 3 (Fig. 6) is in agreement with this hypothesis. However, the fact, that the BTB domain 
is actually dispensable for binding to Cullin 3, complicates the picture. In order to convincingly show that 
KCTD16 and KCTD8 are novel substrate adaptors similar to other BTB proteins, their substrates would 
need to be identified. Substrate identification for substrate adaptors of E3 ligases is a technically 
challenging task due to the principally short‐lived nature of the interaction between substrates and their 
adaptors. Orphan substrate adaptors for E3 ligases are common in the literature (Liu et al., 2013). 
My results further show that Cullin 3 and GABAB2 can be found in the same complex in the presence of 
KCTD16 (Fig. 9). In this regard, the physiological function of KCTD16 may be a molecular linker that 
recruits the CRL3 complex to the GABAB receptor. KCTD16 has been found to act as a molecular linker in 
other contexts as well, for example linking GABAB with effector channels such as HCN2 channels 
(Schwenk et al., 2016). As shown in the second chapter, KCTD16 may also link GABAB to the CaV2.2 
signaling complex. In the case of KCTD8, I was not able to demonstrate a similar molecular linker 
function in the same experiment. Possibly, technical reasons such as lower signal strength and the 
measurement of indirect protein interactions might explain this finding. It should be noted that in my co‐
IP experiments, I observed that KCTD8 has a weaker affinity to Cullin 3 compared to KCTD16, as an 
example see Figure 4A. Based on this lower affinity, one should expect a lower signal for the indirect 
GABAB co‐IP in these experiments. I cannot exclude the possibility that a linker function of KCTD8 could 
be demonstrated by another experimental method. The reason for the weaker Cullin 3‐binding affinity of 
KCTD8 compared to KCTD16 is unknown, but it is likely attributable to amino acid differences in their H2 
domains. 
An obvious hypothesis was that the KCTD16‐CRL3 complex directly ubiquitinates and degrades GABAB 
receptors. The KCTD16‐CRL3 complex does not constitutively down‐regulate GABAB receptor levels (as 
shown in Fig. 10), arguing against this hypothesis. Thus, at the moment the question of the substrates of 
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the observed GABAB‐KCTD16‐CRL3 and KCTD8‐CRL3 complexes remains open. Possible substrates include 
other constituents of the large GABAB interactome. Alternatively, GABAB receptor‐independent functions 
of the KCTD16/8‐CRL3 complexes remain a plausible possibility as well, as the GABAB‐associated KCTDs 
are also expressed in non‐neuronal tissues (Metz et al., 2011). 
In conclusion, my results suggest that through the association with Cullin 3, KCTD16 and KCTD8 play a 
role in ubiquitination signaling in vivo, possibly in the context of GABAB receptors. However, their precise 
functions remain to be elucidated. Recent work has firmly established CRL3s as major regulators of 
different cellular and developmental processes. In humans, several mutations in CRL3 complex 
components have been associated with various pathologies, including metabolic disorders, muscle, and 
nerve degeneration, as well as cancer (Genschik et al., 2013). In this context, I demonstrated that not 
just BTB‐domain containing proteins could be adaptors for CRL3 complexes and as a direct consequence 
this suggests a potential increase of putative adaptors and substrates which are regulated by these 
complexes. Elucidating the molecular mechanism and the functional consequence of the GABAB‐KCTD16‐
Cul3 complex will be important to better understand the regulation of GABAB receptor signaling. 
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Chapter 2: KCTD16 directly interacts with N-type voltage-gated 
calcium channels 
2.1 Introduction 
2.1.1 Voltage-gated calcium channels 
Voltage‐gated calcium channels (VGCCs) play important roles in all excitable tissues, e.g. in the CNS or in 
the heart. As their name implies, their main function is to transduce electrical activity into changes of the 
intracellular level of the important second messenger calcium (Simms and Zamponi, 2014). Historically, 
VGCCs were classified into high‐voltage‐activated (HVA) and low‐voltage‐activated (LVA) channels based 
on early electrophysiological recordings (Fedulova et al., 1985, Mitra and Morad, 1986). Several types of 
VGCCs are known today (as shown in Fig. 11A), which mostly differ in their CaVα1 subunit: the L‐type 
(CaV1.1‐CaV1.4), the P/Q‐type (CaV2.1), the N‐type (Cav2.2), the R‐type (Cav2.3) and the T‐type (Cav3.1‐
Cav3.3) (Ertel et al., 2000, Simms and Zamponi, 2014). As shown in Fig. 11B and C, HVA channels are 
consisting of several subunits: the channel‐forming CaVα1 subunits and the auxiliary CaVβ and CaVα2δ 
subunits (Simms and Zamponi, 2014). L‐type VGCCs also incorporate CaVγ subunits (Simms and Zamponi, 
2014). The auxiliary CaVβ1‐4 and CaVα2δ1‐4 subunits are promiscuous and associate with many 
different CaVα1 subunits (Dolphin, 2003). Native T‐type VGCCs may lack auxiliary subunits (Perez‐Reyes, 
2003). 
Predominantly P/Q‐type and N‐type VGCCs are crucial for synaptic transmission, as they couple neuronal 
activity with vesicle release in the presynapse (Simms and Zamponi, 2014). R‐type VGCCs are also found 
in the presynapse. L‐type VGCCs are mainly found in muscle and cardiac tissue. T‐type VGCCs are present 
in both cardiac and neuronal tissue. The different types of VGCC can be distinguished pharmacologically, 
e.g. N‐type VGCC are specifically inhibited by ω‐conotoxin‐GVIA, a toxin isolated from the marine cone 
snail Conus geographus (Kerr and Yoshikami, 1984). 
 
2.1.2 The pore-forming CaVα1 subunits 
As mentioned above, the different VGCCs are classified into different electrophysiological types on the 
basis of their CaVα1 subunit (Ertel et al., 2000). The pore‐forming CaVα1 subunits are large proteins of 
around 250kDa consisting of four transmembrane domains, each of them made up of six transmembrane 
alpha‐helices (Simms and Zamponi, 2014). The intracellular linkers between the four transmembrane 
segments (labeled I‐IV) contain binding sites for diverse signaling modulators and scaffolds. 
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Figure 11. Voltage-gated calcium channels.  
(A) The family of VGCC is subdivided in several subfamilies. High‐voltage‐activated (HVA) channels open 
when the membrane is heavily depolarized, in contrast to Low‐voltage‐activated (LVA) channels that 
activate already at less depolarized potentials. The HVA channels are further divided into CaV1 and CaV2 
channels. (B) + (C) Schemes of the subunit composition for HVA channels. The principal pore‐forming α1 
subunit associates with regulatory β, α2δ and γ subunits. (D) Regulation of CaV2 channels. Gβγ inhibits 
the channel by binding to three sites distributed on the CaVα1 subunit. PKC phosphorylation is another 
major regulation mechanism. Synaptic proteins such as syntaxin‐1 and SNAREs bind to the so‐called 
Synprint site, thereby coupling the VGCC to the synaptic release machinery. Images adapted from 
(Catterall and Few, 2008) and (Stephens and Mochida, 2013). 
A 
D 
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In order to form functional VGCCs, α1 subunits associate with auxiliary subunits (Arikkath and Campbell, 
2003). Interestingly, recombinantly expressed α1 subunits of T‐type channels elicit similar currents as 
recorded in vivo, therefore it is unclear whether T‐type channels need or are associated with auxiliary 
subunits in vivo (Perez‐Reyes, 2003). 
The presynaptic CaV2.1 and CaV2.2 contain several regulatory binding sites (Fig. 11D), to allow 
modulation of their Ca2+‐influx and consequentially of neurotransmission (Zamponi and Currie, 2013). An 
important binding site is the alpha interaction domain (AID) found on intracellular loop I‐II, where the 
modulatory CaVβ subunits bind (Pragnell et al., 1994). A major regulatory site is found on linker I‐II, 
where Gβγ leads to inhibition of calcium currents (Herlitze et al., 1997). Another crucial site is the so‐
called synaptic protein interaction site (Synprint), which is located on linker II‐III (Rettig et al., 1996). 
SNAP‐25 and syntaxin‐1 are binding to the Synprint site, thereby tethering the VGCC and the release 
machinery together (Rettig et al., 1996, Catterall and Few, 2008). The important calcium sensor 
synaptotagmin 1 also binds to the Synprint site (Sheng et al., 1997). As the presynaptic VGCCs together 
with the vesicle release machinery constitute the core of the presynapse, many different signaling 
pathways converge at this site. Thus, it is not surprising that a multitude of interacting proteins of the 
CaVα1 subunits exist (Müller et al., 2010). VGCCs can also be regulated by phosphorylation through PKC 
and CaMKII kinases using specific sites on the α1 subunit (Zamponi and Currie, 2013). 
 
2.1.3 CaVβ subunits 
In mammalian cells, there are four genes coding for VGCC β subunits (CaVβ1‐4). Additionally, several 
alternative splice forms exist for these genes. The Cavβ subunits consist of variable N‐ and C‐termini as 
well as highly conserved Src homology 3 (SH3) and guanylate kinase (GK) domains, linked together by a 
HOOK domain. The GK domain is catalytically inactive but binds to the CaVα1 AID motif. The SH3 domain 
functions as a protein‐protein interaction module. Overall the structures of CaVβs resemble membrane‐
associated guanylate kinases (MAGUKs). CaVβ subunits are promiscuous and bind to all Cav1 and CaV2 
α1 subunits in heterologous systems (Dolphin, 2003). On the other hand, Cavβ subunits are not found in 
CaV3‐based channels. The CaVβ subunits are soluble intracellular proteins and affect trafficking of the 
VGCCs, thereby strongly enhancing their calcium currents when co‐expressed together with the CaVα1 
subunits (Singer et al., 1991). The β subunits bind to the I‐II linker of the α1 subunits and enhance 
surface expression of VGCCs and Ca2+‐currents (Pragnell et al., 1994). Recently, another VGCC‐
independent function of CaVβ subunits is emerging, as CaVβ subunits regulate the transcriptional activity 
of a certain Pax‐6 isoform (Zhang et al., 2010).  
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2.1.4 CaVα2δ subunits 
Four genes coding for the α2δ subunits are known (CaVα2δ1‐4) (Obermair et al., 2008). Similar to the 
CaVβ subunits, α2δ subunits are promiscuous in their binding to different α1 subunits in recombinant 
systems (Obermair et al., 2008). The α2δ subunits are post‐translationally cleaved into the α2 and the δ 
peptides, which then re‐associate by a disulphide bridge (De Jongh et al., 1990). The α2δ subunit binds to 
CaVα1 in a completely extracellular interaction (Gurnett et al., 1997). Like the CaVβ subunits, the CaVα2δ 
proteins have a role in trafficking of VGCCs and/or enhancing of Ca2+‐currents (Arikkath and Campbell, 
2003). Notably, the α2δ subunit is the pharmacological target for the anti‐epileptic drugs Gabapentin 
and Pregabalin (Gee et al., 1996, Field et al., 1997). 
 
2.1.5 Presynaptic voltage-gated calcium channels 
N‐type and P/Q‐type calcium channels are crucial for neurotransmitter release at the presynaptic 
terminal (Simms and Zamponi, 2014). Voltage changes are sensed by these VGCCs and translated into a 
calcium ion influx that in turn leads to the release of neurotransmitter vesicles (Takahashi and 
Momiyama, 1993). At a molecular level, these VGCCs are highly interconnected with the synaptic release 
machinery through their Synprint domain (Rettig et al., 1996). This Synprint domain is located on the II‐III 
linker of the α1 subunits (Rettig et al., 1996). Several SNARE proteins like syntaxin‐1, synaptotagmin 1 
and SNAP‐25 bind to this site of both CaV2.1‐ and CaV2.2‐based channels. Additional interfaces with the 
synaptic core complex are found on the CaVβ subunits, where the Rab interacting protein (RIM) binds 
(Kiyonaka et al., 2007). Through these redundant connections, CaV2.1 and CaV2.2 VGCCs are located in 
close physical proximity to the release machinery, which likely improves reliability and improves efficacy 
of this pivotal neuronal function (Neher, 1998). 
Given the high relevance of N‐Type and P/Q‐type VGCCs in neurotransmitter release, it is not surprising 
that their function can be modulated by many different players such as GPCRs, protein kinases and 
second messengers (reviewed in Zamponi and Currie, 2013). Several neurotransmitters (e.g. GABA) are 
known to inhibit the calcium currents mediated by these VGCCs and consequentially also presynaptic 
transmitter release (Zamponi and Currie, 2013). Gβγ inhibition of presynaptic VGCCs is mediated by 
several binding sites for Gβγ on the α1 subunits (Herlitze et al., 1997, Cantı ́et al., 1999, Li et al., 2004). 
Presynaptic calcium channels are found in large protein complexes reflecting their important role in 
neurotransmission. A proteomics study of rat CaV2 channels (CaV2.1‐CaV2.3) has shown a vast 
interactome of around 200 protein partners associated with these three VGCCs (Müller et al., 2010), 52 
protein interactors are shared by all CaV2 channels. N‐type VGCCs share an additional 47 putative 
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binding partners with P/Q‐type and 19 interactors with R‐type channels. Interestingly, the GABAB 
receptor and its auxiliary subunits KCTD12, KCTD8 and KCTD16 were also found to be specifically 
associated with N‐type VGCCs (Müller et al., 2010). 
 
2.1.6 GPCR-mediated modulation of presynaptic VGCCs 
As a consequence of their pivotal role in neurotransmission, the presynaptic P/Q‐ and N‐type VGCCs are 
known to be modulated by many different neurotransmitters such as GABA, glutamate, acetylcholine, 
monoamines (Zamponi and Currie, 2013). The mechanism for this form of modulation of VGCCs mostly 
consists in activating presynaptic GPCRs. There are two well‐known forms of GPCR‐mediated inhibitions 
of presynaptic VGCCs (Zamponi and Currie, 2013). 
The first mechanism is a fast‐acting inhibition mediated by the released Gβγ heterodimer. As described 
before, Gβγ is interacting with several sites on the CaVα1 subunit leading to inhibition of the VGCCs 
(Herlitze et al., 1997, Cantı ́et al., 1999, Li et al., 2004). Gβγ inhibits VGCCs by causing a positive shift in 
their voltage‐dependence. The shift in voltage‐dependence can be overcome by stronger depolarization 
such as trains of action potentials (Brody and Yue, 2000). This fast, direct Gβγ‐inhibition is caused by Gi/o‐
coupled receptors such as the GABAB‐receptor (Cardozo and Bean, 1995). The Gβγ‐inhibition is sensitive 
to Pertussis toxin (PTX), as PTX inhibits the necessary Gi/o protein signaling (Zamponi and Currie, 2013). 
In contrast to the fast Gβγ voltage‐dependent inhibition, there is a second slower form of inhibition, 
which is voltage‐independent. The mechanisms for this form of inhibition of VGCCs depend on several 
intracellular signaling pathways. Several Gq‐coupled receptors like muscarinic and metabotropic 
glutamate receptors inhibit VGCCs in this manner (Bernheim et al., 1991, Takahashi et al., 1996). 
In addition to the two forms of inhibition described above, direct protein interactions of GPCRs with 
VGCCs might change their signaling and/or expression levels on the plasma membrane. Examples for this 
type of modulation are that metabotropic glutamate receptors regulate CaV2.1 responses (Kitano et al., 
2003) or that nociception receptors change internalization and expression levels of N‐type calcium 
channels (Altier et al., 2006, Evans et al., 2010). 
 
In this chapter, I demonstrate that the GABAB auxiliary subunit KCTD16 directly binds to CaV2.2 and 
describe relevant binding sites for this protein‐protein interaction. Furthermore, I confirm the 
interactions between the GABAB receptor and N‐type VGCCs as well as syntaxin‐1 in mouse brains. The 
described protein CaV2.2‐KCTD16 interaction has important electrophysiological effects on N‐type 
VGCCs. 
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2.2 Materials and Methods 
Expression plasmids 
pCI‐Myc‐KCTD constructs (myc‐KCTD12, myc‐KCTD16, myc‐KCTD8, myc‐KCTD16ΔH2, myc‐KCTD16H1H2, 
myc‐KCTD16H2, myc‐KCTD12‐16H2) were described earlier (Seddik et al., 2012). 
The pCDNA3‐CaVβ1b and pCDNA3‐CaV2.2 plasmids were gifts from Linda Haugaard‐Kedstrom. 
pCI‐GFP‐I‐II‐Flag was made by standard PCR cloning. First, CaV2.2 loop I‐II was amplified with a C‐
terminally Flag tag peptide flanked by the restriction sites MluI on the N‐terminus and XmaI on the C‐
term. This fragment was subcloned into an empty pCI expression vector. Afterwards, EGFP was amplified 
flanked by EcoRI and MluI and ligated into pCI‐I‐II‐Flag to give rise to pCI‐GFP‐I‐II‐Flag. 
 
Cell culture 
COS‐1 cells were maintained in DMEM (Life Technologies, CA, US) + 10% FCS (GE Healthcare, 
Buckinghamshire, UK) in a cell culture incubator set to 37°C with 5% CO2. A stably transfected CHO‐
CaV2.2 cell line (CHO N‐VGCC) was provided by B. Fakler (Universität Freiburg). CHO N‐VGCC were 
maintained in MEM Alpha (Gibco, 2271‐020) + 10% FCS (GE Healthcare, Buckinghamshire, UK) 
supplemented with 700µg/ml G418 (Geneticin), 250µg/ml Hygromycin B, and 5µg/ml Blasticidin.  
Cells were split twice a week for regular cultivation.  
Cell transfection was done using Lipofectamine 2000 (Life Technologies) according to the manufacturer's 
protocol. DNA amounts were equalized by empty pCI Vector DNA (Promega, WI, US). 
 
Co-immunoprecipitation and Western Blot 
Between 24 and 48 hours after transfection, COS‐1 or CHO N‐VGCC cells were washed in ice‐cold PBS 
and lysed in NETN buffer (100mM NaCl, 20 mM Tris, 1mm EDTA, 0.5% NP40, pH 7.4) supplemented with 
complete protease inhibitors (Roche, Basel, Switzerland). Lysates were then used for Western Blot 
(Input) or immunoprecipitations. Immunoprecipitations were done using magnetic Protein G beads 
(Dynabeads, 10004D, Life Technologies) according to the manufacturer’s protocol. Briefly, lysates and 
antibody coupled to beads were incubated for 10min at room temperature, beads were washed four 
times with NETN buffer and eluted with 1x Lämmli Buffer. Input and IPs were resolved with standard 
SDS‐PAGE on 6‐12% acrylamide gels. 
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Antibodies list 
 
Name  Host  Company  Product Nr. WB  IP 
Anti‐Flag M2 mouse  Sigma   F1804  ‐  2µl 
Anti‐Flag rabbit  Sigma   F7425  1:1’000  ‐ 
Anti‐myc, 9e10 mouse  Santa Cruz  sc‐40  ‐  5µl 
Anti‐myc rabbit  Sigma   C3956  1:1’000  ‐ 
Anti‐CaV2.2 rabbit  Millipore  AB5154  1:500  ‐ 
Anti‐CaVβ1 rabbit  Abcam   ab28502 1:1’000  ‐ 
Anti‐GFP Rabbit  Invitrogen  A‐11122  1:1000  ‐ 
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2.3. Results 
2.3.1 The CaV2.2 α1 subunit specifically interacts with KCTD16 in absence of GABAB 
As both the GABAB‐receptor as well as the associated KCTDs have been identified to be part of the 
interactome of N‐type voltage‐gated calcium channels (Müller et al., 2010), it is of interest whether the 
KCTD proteins are able to directly bind to CaV2.2 channel complexes themselves. To test KCTD‐binding to 
the CaV2.2 in absence of the GABAB receptor, I carried out co‐immunoprecipitation experiments in a 
CHO cell line stably expressing CaV2.2, CaVβ‐ and CaVα2δ‐subunits (CHO N‐VGCC). The results show that 
the CaV2.2 α1 subunit specifically binds to KCTD16 (Fig. 12A). On the other hand, KCTD12 and KCTD8 did 
not show significant CaV2.2‐binding under these conditions. In another set of experiments done in 
transfected COS‐1 cells, this specific CaV2.2‐KCTD16 interaction was confirmed (Fig. 12B). In these 
experiments, only CaV2.2 and CaVβ1b were co‐transfected with the KCTDs. Therefore, the requirement 
of CaVα2δ subunits for the CaV2.2‐KCTD16 interaction can be excluded on the basis of these 
experiments. Next, I tested the requirement of the CaVβ1b subunit for the CaV2.2‐KCTD16 interaction in 
transfected COS‐1 cells. In these co‐immunoprecipitation experiments, I found that the isolated CaV2.2 
α1 subunit was sufficient for the interaction with KCTD16 (Fig. 12C). This suggests that KCTD16 could act 
as a molecular linker between the GABAB receptor and N‐type VGCCs (see 2.4).  
 
2.3.2 KCTD16 does not interact with the β subunit of voltage-gated calcium channels 
Voltage‐gated calcium channels are consisting of three principal subunits: a channel‐forming α1 subunit, 
a CaVβ subunit and a CaVα2δ subunit. So far, I found the specific interaction of KCTD16 with CaV2.2, 
which is the α1 subunit of N‐type VGCCs. It is interesting to know whether KCTD16 binds to other 
subunits of VGCCs as well. A priori, the α2δ subunit is not very likely to bind to KCTD16, as α2δ only has a 
small intracellular portion. Therefore, I checked for a possible interaction of KCTD16 with the CaVβ 
subunit. To test binding of KCTD16 to the VGCC β subunit, co‐immunoprecipitation experiments in COS‐1 
cells were conducted (Fig. 12D). The obtained results indicate that neither KCTD16 nor KCTD12 directly 
bind to the CaVβ1b subunit. Although I only tested CaVβ1b, it is likely that KCTD16 does not directly bind 
to CaVβ subunits (see 2.4). 
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Figure 12. The CaV2.2 α1 subunit specifically binds to KCTD16. 
(A) Co‐immunoprecipitation experiments using transfected CHO N‐VGCC cells. The CaV2.2 channel 
complex specifically binds to KCTD16. (B) Co‐immunoprecipitation experiments using transfected COS‐1 
cells. KCTD16 binds to CaV2.2 in the presence of CaVβ1b. (C) Co‐immunoprecipitation experiments using 
transfected COS‐1 cells. KCTD16 also binds to the isolated CaV2.2 α1 subunit; therefore the presence of 
the CaVβ1b subunit is not required for the CaV2.2‐KCTD16 interaction. Asterisks indicate non‐specific 
bands in the input. Note that there are two non‐specific bands in the KCTD16 input, the higher one of 
them is overlapping with the specific band of KCTD16. (D) Co‐immunoprecipitation experiments using 
transfected COS‐1 cells. Neither KCTD16 nor KCTD12 bind to the isolated CaVβ1b subunit. 
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2.3.3 The H2 domain of KCTD16 is important for the CaV2.2-KCTD16 interaction 
In order to identify the KCTD16 domain involved in the interaction with CaV2.2, I expressed different 
KCTD constructs in CHO N‐VGCC cells and carried out co‐immunoprecipitation experiments (Fig. 13A+B). 
I found that full length KCTD16 bound strongest to CaV2.2, while KCTD12 was completely unable to bind. 
The deletion of the H2 domain of KCTD16 dramatically diminished the binding. The 16H1H2 construct, 
consisting of the H1 and H2 domains of KCTD16, was found to be the minimal construct capable of 
binding to CaV2.2. Interestingly, CaV2.2‐binding can be transferred to KCTD12 by fusing the H2 domain 
of KCTD16 to KCTD12. As the H1 domain in this chimeric construct stems from KCTD12, which alone is 
unable to bind to CaV2.2, this emphasizes the importance of the H2 domain of KCTD16 for CaV2.2‐
binding. However, the isolated H2 domain of KCTD16 was not sufficient on its own. The reason for the 
requirement of an H1 domain could be that the isolated H2 domain is weakly expressed and possibly not 
properly folded. 
 
2.3.4 The intracellular loop I-II of CaV2.2 is sufficient to co-precipitate KCTD16 
The results gathered so far are consistent with the hypothesis that KCTD16 directly binds to the pore‐
forming CaV2.2 α1 subunit. Gβγ is known to inhibit VGCCs by binding to several sites on the α1 subunit. 
A major binding site for Gβγ on CaV2.2 is found on the intracellular loop I‐II (Herlitze et al., 1997). As 
KCTD16 is binding to the Gβγ heterodimer (Turecek et al., 2014), the possibility that KCTD16 interacts 
with Gβγ at the intracellular loop I‐II and thereby change CaV2.2 channel currents is an attractive 
hypothesis. To check whether KCTD16 interacts with the intracellular loop I‐II of CaV2.2, I tagged the 
intracellular loop I‐II with GFP at the N‐terminus and with Flag at the C‐terminus and performed co‐
immunoprecipitations in COS‐1 cells. I found that the GFP‐I‐II‐Flag construct was able to specifically co‐
precipitate KCTD16 (Fig. 13D). These results suggest a direct protein‐protein interaction between KCTD16 
and the intracellular loop I‐II, as there are no endogenous VGCC subunits expressed in COS‐1 cells (Harry 
et al., 2004). 
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Figure 13. Characterization of the CaV2.2‐KCTD16 interaction.  
(A) Scheme of the KCTD constructs used for domain mapping of the CaV2.2 interaction site on KCTD16.  
(B) Co‐immunoprecipitation experiments with transfected CHO N‐VGCC cells using the KCTD constructs 
depicted in (A). The 16H1H2 construct was found to be the minimal deletion construct to bind to CaV2.2, 
as the isolated H2 domain was not sufficient. CaV2.2‐binding could be transferred to KCTD12 by fusing 
the H2 domain of KCTD16 to KCTD12 (12‐16H2). This highlights the importance of the H2 domain for the 
interaction with CaV2.2. (C) Diagram of the protein domains of CaV2.2. CaV2.2 consists of four large 
transmembrane domains connected by intracellular loops. The intracellular loop I‐II contains the alpha 
interaction domain (AID), which interacts with the CaVβ subunits, and also binds to Gβγ. The intracellular 
loop II‐III features the Synprint domain for interacting with several synaptic proteins. (D) Co‐
immunoprecipitation experiments with transfected COS‐1 cells. The intracellular loop I‐II of CaV2.2 is 
sufficient to co‐precipitate KCTD16. 
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2.3.5 GABAB associates with N-type calcium channels and syntaxin-1 in mouse brain tissue 
Presynaptic N‐type channels are coupled to both GABAB receptors and the neurotransmitter release 
machinery. For this reason, I decided to study whether endogenous GABAB receptors are found in 
complex with CaV2.2 and syntaxin‐1 in mouse brain tissue. To test this, I performed co‐
immunoprecipitations using mouse brain membrane preparations. By immunoprecipitating with an anti‐
GABAB1‐specific antibody, both CaV2.2 and syntaxin‐1 were confirmed as part of GABAB receptor 
complexes (Fig. 14). The results of these experiments are already published, as Figure S9 in (Vertkin et 
al., 2015), also see appendix for this publication. 
 
Figure 14. Endogenous GABAB receptors co-immunoprecipitate with syntaxin-1 and CaV2.2. 
(A‐B) Solubilized brain membranes from WT, 1b‐/‐ and 1‐/‐ mice were immunoprecipitated (IP) with anti‐ 
syntaxin‐1 (A) and anti‐CaV2.2 (B) antibodies and analyzed by western blotting with the indicated 
antibodies. Of note, the anti‐GB1 antibody recognizes the common C‐terminus of GB1a and GB1b. 
Asterisk indicates a cross‐reacting band visible after the long exposure required for detection of GABAB 
receptors in anti‐syntaxin‐1 IPs. Left panels show input brain membranes used for immunoprecipitation. 
MW, molecular weight. 
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2.3.6 Electrophysiological effects of KCTD16 on N-type VGCCs 
To understand the physiological relevance of the CaV2.2‐KCTD16 interaction, patch‐clamp recordings 
were performed using transfected CHO N‐VGCC cells (R. Turecek). These recordings of calcium currents 
were carried out under blockade of potassium currents and chelation of intracellular calcium by EGTA, to 
isolate specific calcium currents from N‐type VGCCs. 
Co‐expression of KCTD16 showed a number of effects on the activation of N‐type VGCCs. As shown in 
Fig. 15A‐C, KCTD16 shifted the voltage‐dependence of N‐type VGCCs to more hyperpolarized potentials 
by about 10mV. Furthermore, KCTD16 strongly increased and accelerated calcium currents in these 
recordings. This shift in voltage‐dependence of N‐type VGCCs is clearly KCTD16‐specific, as KCTD12 did 
not similarly alter activation potentials, as shown in Fig. 15D. Furthermore, the effect of KCTD16 on 
activation of N‐type VGCCs persists in the presence of GABAB receptors (Fig. 15D).  
Previously, I found that the intracellular loop I‐II of CaV2.2 binds to KCTD16 (see Fig. 13D). To test 
whether the effect of KCTD16 on N‐type VGCCs can be inhibited by co‐expression of this intracellular 
loop construct, patch‐clamp recordings were done of CHO N‐VGCC cells transfected with different 
constructs. As was observed before, KCTD16 shifted the activation of N‐ype VGCCs to more 
hyperpolarized potentials. Interestingly, co‐expression of the GFP‐I‐II‐Flag construct was able to 
completely block this KCTD16‐induced shift in voltage‐dependence (Fig. 15E), whereas transfection of 
GFP‐I‐II‐Flag alone did not significantly change voltage‐dependence. As shown in Fig. 15F, transfection of 
GFP‐I‐II‐Flag per se did not significantly alter conductance density of these cells compared to the control 
condition without KCTDs, suggesting that it does not measurably change the expression of N‐type VGCCs. 
These data support my previous finding that KCTD16 interacts with the intracellular loop I‐II of CaV2.2 
and suggest that this direct interaction changes important physiological parameters of N‐type VGCCs 
such as voltage‐dependence and current amplitudes. 
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Figure 15. KCTD16 shifts voltage-dependence of N-type VGCCs to more hyperpolarized potentials. 
(A) Traces of N‐type calcium currents evoked by voltage steps from ‐80 to +60mV in 20mV increments. 
Recordings were done with CHO N‐VGCC cells transfected with or without KCTD16. (B) Current‐voltage 
relationship of calcium currents shown in (A). KCTD16 shifts activation of N‐type VGCCs to more 
hyperpolarized potentials and increases calcium currents. (C) Normalized calcium tail‐current amplitudes 
fitted by Boltzmann equation. (D) KCTD16 significantly shifts activation of N‐type calcium channels to 
more hyperpolarized potentials by about 10mV. KCTD12 does not show this effect. The KCTD16 effect 
persists in the presence of the GABAB receptor. (E) The KCTD16 effect on the activation of N‐type calcium 
channels can be blocked by co‐transfection of the intracellular loop I‐II construct. Transfection of the 
intracellular loop I‐II alone does not significantly affect activation of N‐type VGCCs. (F) Transfection of the 
intracellular loop I‐II also does not change conductance density. By courtesy of R. Turecek.  
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In conclusion, it was demonstrated that the GABAB auxiliary subunit KCTD16 directly binds to the pore‐
forming CaV2.2 subunit and the relevant binding sites for this protein‐protein interaction were 
described. Furthermore, the interactions between the GABAB receptor and N‐type VGCCs as well as 
syntaxin‐1 were confirmed in mouse brain tissue. The described protein CaV2.2‐KCTD16 interaction has 
important electrophysiological effects on N‐type VGCCs, which can be blocked by co‐expression of the 
KCTD16‐binding intracellular loop I‐II of CaV2.2.  
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2.4 Discussion 
For some time, GABAB receptors are known to regulate N‐type VGCCs through Gβγ inhibition (Cardozo 
and Bean, 1995). GABAB receptors as well as their associated KCTDs were shown to be part of the 
interactome of these channels (Müller et al., 2010). However, the precise biochemical interconnections 
and functions of these large protein complexes are not yet fully understood. First, I tested whether N‐
type VGCCs also bind to GABAB‐associated KCTDs in absence of GABAB receptors. In transfected CHO N‐
VGCC and COS‐1 cells, CaV2.2 was found to only directly bind to KCTD16 (Fig. 12). This is in contrast to 
the available proteomics data of mouse brain tissue, where also KCTD12 and KCTD8 have been found to 
be associated with CaV2.2 (Müller et al., 2010). It has to be considered that the experiments presented 
here were done in recombinant systems, so this discrepancy can be explained either by 
heteromerization of these KCTDs or recruitment of GABAB complexes to CaV2.2 by additional molecular 
linkers in native tissue. Both of these possibilities are very plausible, as heteromerization of KCTDs is 
indeed occurring (T. Fritzius, personal communication) and given the existence of multiple mutual 
interaction partners of both CaV2.2 and GABAB receptors such as Gβγ, SNARE proteins, 14‐3‐3 proteins 
etc. (Müller et al., 2010). For this reason, I chose to use a recombinant system, where the advantage was 
to have isolated components, in order to test the specificity of KCTD16‐CaV2.2 direct interaction. 
I found that the pore‐forming CaV2.2 α1 subunit specifically binds to KCTD16. Of course, this does not 
exclude other VGCC subunits binding to KCTD16 as well. The predominantly transmembrane and 
extracellular CaVα2δ and CaVγ subunits are unlikely to interact with KCTD16 because of their different 
intracellular locations. I showed that KCTD16 was unable to bind to the isolated CaVβ1 subunit (Fig. 12D). 
Of note, there is a high amino acid identity of more than 60% between different CaVβ subunits (Stephens 
and Mochida, 2013) and CaVβ subunits are promiscuous in their binding to CaVα1 subunits. In 
electrophysiological recordings of hippocampal neurons, KCTD16 specifically altered N‐type VGCC 
currents, as observed by a pharmacological blocking of N‐type channels by ω‐Conotoxin‐GVIA (R. 
Turecek, personal communication). If KCTD16 directly interacted with CaVβ subunits, one would expect 
to see similar electrophysiological changes for several types of HVA channels as well, because of 
promiscuous CaVβ‐CaVα1 associations. On these grounds, I argue that KCTD16 do not interact via CaVβ 
subunits. Similarly to KCTD16, KCTD12 was also unable to bind to CaVβ1b (Fig. 12D). This finding is 
interesting, as SNPs for both KCTD12 and CaVβ2 have been identified in a bipolar I disorder genome‐
wide association study (Lee et al., 2011). CaVβ1b and CaVβ2 are highly similar (Stephens and Mochida, 
2013), thus these results tentatively suggest that KCTD12 might not directly bind to CaVβ2. Even in the 
absence of direct protein‐protein interactions with CaVβ subunits, KCTD12 potentially regulates VGCC‐
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signaling, e.g. by heteromerizing with KCTD16 or by generally interfering with Gβγ‐signaling (Turecek et 
al., 2014). 
Furthermore, I have demonstrated the importance of the C‐terminal H2 domain of KCTD16 for CaV2.2‐
binding. This is reminiscent of the HCN2‐binding to KCTD16, where deletion of the C‐terminus of KCTD16 
was shown to abolish the molecular interaction between the HCN2 channel and KCTD16 (Schwenk et al., 
2016). Similarly, the H2 domains of KCTD16 and KCTD8 were shown to be required for Cullin 3‐binding in 
the first chapter of this thesis. Of note, KCTD16 is binding to GABAB2 by its N‐terminal T1 domain. 
Therefore, KCTD16 is most likely able to bind both the CaV2.2 channel and the GABAB receptor 
simultaneously. KCTD16 might therefore act as a molecular linker that couples the GABAB receptor to the 
N‐type VGCCs. The direct KCTD16‐CaV2.2 protein‐protein interaction reflects the importance of 
presynaptic release regulation, physically linking GABAB receptors to N‐type calcium channel complexes. 
A major function of this interaction is the modulation of biophysical properties of N‐type calcium 
channels, also in a GABAB‐activity‐dependent way (see discussion below). For quite some time, the 
GABAB receptor and other GPCRs have been known to modulate N‐type VGCCs. One well established 
pathway of GPCR‐mediated modulation of VGCCs activity consists of Gβγ inhibition through multiple 
binding sites on presynaptic CaVα1 subunits (Herlitze et al., 1997, Zamponi et al., 1997, Cantı ́et al., 1999, 
Li et al., 2004). 
The finding that the intracellular loop I‐II is able to co‐precipitate KCTD16 is interesting, as this site is 
known to bind to Gβγ as well as to CaVβ subunits. It is known that KCTD16 also interacts with the Gβγ 
heterodimer (Turecek et al., 2014). This raises the intriguing possibility that KCTD16 changes Gβγ‐
mediated inhibition of N‐type calcium channels by directly interfering with the Gβγ heterodimer. For 
other effector channels of GABAB receptors like GIRK and HCN2 channels, it is known that KCTDs play a 
role in GABAB‐mediated effector responses. In the case of GIRK channels, KCTD12 desensitizes channel 
responses by competing with the released Gβγ heterodimer (Turecek et al., 2014).  
Finally, I confirmed the biochemical associations of the GABAB receptor with both N‐type VGCCs and 
syntaxin‐1 by co‐immunoprecipitations in mouse brain membranes (Vertkin et al., 2015). Both protein 
interactions have been previously identified in a large‐scale proteomics study (Müller et al., 2010). 
However, this is the first biochemical study showing that GABAB receptors are physically linked to both 
presynaptic VGCCs and the presynaptic vesicle release machinery. My results suggest that KCTD16 could 
act as a molecular linker that precouples GABAB receptors, which are bound to KCTD16 through its T1 
domain, to N‐type VGCCs. 
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Currently, an electrophysiological characterization of the CaV2.2‐KCTD16 interaction is ongoing. So far, 
the physiological relevance of the interaction was tested by electrophysiological recordings of CHO N‐
VGCC cells transfected with KCTD16, where the following observations were made (R. Turecek, personal 
communication). KCTD16 was found to change the biophysical properties of N‐type channels in several 
ways in the absence of GABAB receptors. First, KCTD16 shifts the voltage‐dependence of N‐type VGCCs to 
more hyperpolarized potentials (by about 10 mV). Second, KCTD16 also increases permeability for 
divalent cations in these channels. Third, KCTD16 accelerates the kinetics of N‐type VGCC activation. 
Fourth, KCTD16 decreases sensitivity of N‐type channels to and decelerates the kinetics of GABAB‐
mediated inhibition. 
Interestingly, the KCTD16 effect on N‐type calcium channels could be blocked by co‐expression of the 
intracellular loop I‐II of CaV2.2 (Fig. 15E), confirming that this loop is a relevant binding site for KCTD16. 
This short intracellular loop I‐II of around 130 amino acids contains several different regulation sites such 
as a Gβγ‐site, the AID as well as phosphorylation sites. A further dissection of the KCTD16‐binding site 
could provide valuable additional information on the mechanism of the KCTD16‐modulation of N‐type 
VGCCs. 
The same modulation by KCTD16 was also observed for native neuronal N‐type channels in hippocampal 
neurons. This modulation was demonstrated to be N‐type specific using pharmacological inhibition of N‐
type currents, as hippocampal neurons also express different types of VGCC, such as P/Q‐type or L‐type 
channels. As both P/Q‐type and N‐type VGCCs are implicated in the same biological context of 
presynaptic neurotransmitter release, it remained an open possibility whether KCTD16 binds to other 
CaVα1 subunits than CaV2.2, as GABAB receptors were also shown to be slightly enriched in CaV2.1 
(Müller et al., 2010). However, based on these observations, this seems not to be the case. 
The underlying molecular mechanism for the KCTD16 effects on N‐type currents is unknown. It could be 
mediated by the direct interactions of KCTD16 with the intracellular linker I‐II and/or Gβγ. Of note, all 
effects of KCTD16 on the channel are similar (or synergistic?) to CaVβ‐mediated effects, therefore 
another possibility is that KCTD16 enhances CaV2.2‐CaVβ interactions. As mentioned, CaVβ does not 
seem to be the direct binding partner of KCTD16, as suggested by my co‐IP results (Fig. 12D) and by the 
specificity of KCTD16 effects for N‐type currents. 
 
Together, these studies shed light on presynaptic regulation by GABAB receptors, not just through 
secondary effectors, but also by direct interaction with the presynaptic release machinery, leading to 
important implications in synaptic strength modulation and hence for learning and memory. 
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Final Conclusions 
The prevalent inhibitory neurotransmitter gamma‐aminobutyric acid (GABA) acts through the ionotropic 
GABAA and the metabotropic GABAB receptors. Functional GABAB receptors are Gi/o protein‐coupled 
receptors, consisting of an obligate heterodimer of GABAB1 and GABAB2 subunits (Kaupmann et al., 
1998a). Several aspects of GABAB signaling could not be explained by these two principal subunits alone. 
A few years ago, a new source of molecular diversity for GABAB receptors was found with the discovery 
that the members of a subfamily of KCTDs, consisting of KCTD8, KCTD12, KCTD12b and KCTD16, 
constitute auxiliary subunits of these receptors (Schwenk et al., 2010). 
The aim of this thesis was to study some of the roles that KCTDs play in GABAB signaling, especially in 
regard to the interconnection of GABAB receptors to other downstream signaling complexes. Being 
intracellular molecules binding to the GABAB2 subunit as well as to the heterotrimeric G proteins 
(Schwenk et al., 2010, Turecek et al., 2014), these KCTDs seem ideally suited to function as scaffold 
molecules connecting the GABAB receptor core complex to effector and signaling complexes, thereby 
enabling or enlarging the functional consequences of GABAB receptors in neurons. 
In conclusion, the results of this thesis corroborate the concept that KCTD16 and KCTD8 extend the 
connectivity of GABAB receptors to both classical and non‐classical effector and regulatory systems by 
acting as molecular linkers. In this work, I described two of these directly KCTD16/8‐associated protein 
complexes: chapter one describes the biochemical connection of KCTD16 and KCTD8 with the Cullin 3‐
RING E3 ligase (CRL3) system, while chapter two is concerned with the KCTD16 interaction with N‐type 
voltage‐gated calcium channels. 
The results of chapter one are relevant in so far, as the biochemical connections of KCTD16 and KCTD8 to 
CRL3 are new. These interactions were not reported in published proteomic studies and the GABAB‐
associated KCTDs were proposed to lack Cullin 3‐binding properties, on the basis of limited experimental 
evidence with KCTD12 (Smaldone et al., 2015). Furthermore, the results show a novel Cullin 3‐binding 
mechanism for KCTD8 and KCTD16 that is not relying on the canonical Cullin 3‐binding BTB domain, 
unlike other substrate adaptors of CRL3 complexes (Furukawa et al., 2003, Genschik et al., 2013). This 
finding is not only relevant for the GABAB receptor‐associated KCTDs, but might also expand the 
spectrum of possible Cullin 3 interactors beyond BTB family proteins, as the BTB domains of KCTD16 and 
KCTD8 were shown to be completely dispensable for their association with Cullin 3. Finally, I 
demonstrated that the CRL3 complex can be recruited to the GABAB receptor by KCTD16, suggesting that 
CRL3 potentially regulates GABAB receptors or secondary proteins bound in the GABAB complex through 
ubiquitination. Unlike with KCTD16, a CRL3‐recruitment to GABAB receptors via KCTD8 could not be 
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demonstrated with my experiments and two alternatives may explain this finding. The first explanation is 
a technical one, as the weaker affinity of KCTD8 for Cullin 3 and the expectedly low signal for indirect co‐
IPs could explain this finding and more sensitive techniques might find these complexes. Second, the 
possibility that the KCTD16‐CRL3 and the KCTD8‐CRL3 interactions have functions independently of 
GABAB receptors cannot be completely excluded with the data at hand. In this context, it is worth 
mentioning that the largest fractions of KCTD12 and KCTD16 are co‐migrating with GABAB receptors in 
native gels of brain tissue suggesting close assembly of the KCTDs with GABAB receptors in the brain 
(Schwenk et al., 2010, Turecek et al., 2014). However, these KCTDs are also expressed in other tissues 
than the brain (Metz et al., 2011), so GABAB‐independent functions of KCTDs remain possible in other 
tissues. 
On the other hand, N‐type VGCCs are classical effectors of GABAB receptors and the results of chapter 
two of this thesis refine understanding of GABAB signaling with respect to these presynaptic channels 
crucial for presynaptic regulation of neurotransmission. The Gβγ‐inhibition of N‐type calcium channels by 
GABAB receptors was known for quite some time. Here, I present data that KCTD16 is directly binding to 
CaV2.2, which represents the pore‐forming α1 subunit of N‐type VGCCs. Therefore, GABAB receptors are 
not solely coupled to CaV2.2 through Gβγ‐signaling but also by a direct biochemical assembly via the 
auxiliary subunit KCTD16. Furthermore, KCTD16 is shown to associate with the intracellular loop I‐II of 
CaV2.2. Interestingly, this important regulatory loop also features the CaVβ‐ and Gβγ‐binding sites, thus 
this interaction is functionally relevant. The physiological relevance of this protein‐protein interaction 
was further established, as an electrophysiological characterization of the CaV2.2‐KCTD16 association 
showed diverse effects on N‐type VGCC currents. Finally, the protein‐protein interactions of GABAB 
receptors with CaV2.2 and the synaptic protein syntaxin‐1 were confirmed in mouse brain tissue, 
demonstrating that GABAB receptors are indeed part of the CaV2.2 complex. This last finding is already 
published (Vertkin et al., 2015). 
Interestingly, for all the protein‐protein interactions studied in this thesis, the H2 domains of KCTD16 or 
KCTD8 were identified as the necessary molecular determinants. The H2 domain was previously shown 
to also have an inhibitory effect on KCTD‐mediated desensitization of GABAB receptor signaling, the 
proposed mechanism for this was sterical hindrance (Seddik et al., 2012). A steric mechanism also makes 
sense in the light of the new findings, as protein‐protein interactions through the H2 domain 
dramatically change the three‐dimensional surroundings of the H1 domain, which is mediating the 
desensitization of GABAB receptors. 
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Of the KCTDs associated with the GABAB receptor, especially KCTD16 now emerges as an important hub 
for different connections of GABAB receptors to several different signaling complexes (as shown in Fig. 
16), such as the hyperpolarization‐activated cyclic nucleotide–gated cation 2 (HCN2) channels (Schwenk 
et al., 2016), two different 14‐3‐3 proteins (Schwenk et al., 2016), CRL3 complexes and N‐type VGCCs. As 
mentioned, N‐type VGCCs are classical effectors of GABAB receptors (Gassmann and Bettler, 2012), while 
HCN2 channels represent a new effector system (Schwenk et al., 2016). Cul3 and 14‐3‐3 proteins may 
mediate new regulatory mechanisms for GABAB receptors, perhaps important at specific steps in the life 
cycle of GABAB, e.g. trafficking or endocytosis. These functional connections also depend on the specific 
cellular context of the individual receptor, e.g. the KCTD16‐connection to N‐type VGCCs is relevant for 
presynaptic release, while HCN2 channels are associated with GABAB receptors in dopaminergic neurons 
of the ventral tegmental area (Schwenk et al., 2016). 
 
Figure 16. KCTD16 extends the connectivity of the GABAB receptor complex to different regulation and 
effector systems. The core GABAB receptor complex (consisting of the GABAB heterodimer and 
heterotrimeric G proteins) binds to the T1 and H1 domains of KCTD16, while the C‐terminal H2 domain 
of KCTD16 is necessary for further connectivity to effector systems such as HCN2 or CaV2.2 channels or 
other regulators like 14‐3‐3 proteins or the CRL3 system. Other protein‐protein interactions of KCTD16 
remain to be further studied, one of them is synaptotagmin 11 (Syt11). A role for KCTDs in the 
connection to DPP was proposed, but remains to be clarified (Schwenk et al., 2016).  
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In contrast to KCTD16, KCTD12 does not exhibit a similar scaffolding function and its main functions likely 
remain mediating the desensitization of GABAB receptor responses through the interaction with Gβγ and 
upregulation of surface GABAB levels (Schwenk et al., 2010, Ivankova et al., 2013, Turecek et al., 2014, 
Booker et al., 2016). 
Regarding the scaffolding function, KCTD8 can be seen as a functional intermediate between KCTD12 and 
KCTD16, as KCTD8 possesses some of the linker functions that were shown for KCTD16. For example in 
this work, it was demonstrated that KCTD8 associates with CRL3 complexes, albeit with a weaker affinity 
than KCTD16. However, some of the protein‐protein interactions are KCTD16‐specific and are not found 
with KCTD8, as seems to be the case for HCN2 channels (Schwenk et al., 2016) and for N‐type VGCCs, as 
shown in this study. These functional differences likely stem from amino acid differences in the H2 
domains of KCTD16 and KCTD8. Of note, expression of KCTD16 is more widespread in the brain 
compared to KCTD8 (Metz et al., 2011), suggesting that the scaffolding functions for GABAB receptor 
complexes in vivo is mostly conferred by KCTD16 rather than KCTD8. 
It has to be emphasized that an individual GABAB receptor‐heterodimer may not exclusively incorporate 
only one specific KCTD subunit at a given time, as KCTD proteins generally form oligomers (Skoblov et al., 
2013) and the GABAB‐associated KCTDs are also able to form heteromers among themselves (T. Fritzius, 
personal communication). Therefore, GABAB receptors can be associated with several different KCTD 
subunits simultaneously, which greatly increases the possible molecular diversity of native GABAB 
receptors. The repertoire of available GABAB receptors in specific neurons is determined by the brain 
expression patterns of the different KCTD auxiliary subunits (Metz et al., 2011). KCTD16 and KCTD12 are 
endogenously co‐expressed in several brain areas, notably in pyramidal neurons and dentate granule 
cells of the hippocampus suggesting GABAB receptors may form complexes with KCTD16/12‐
heterodimers in these areas (Metz et al., 2011). On the other hand, KCTD12, KCTD12b and KCTD8 are co‐
expressed together in the medial habenula (Metz et al., 2011). In contrast, cells in the cerebellum 
probably express only one KCTD subunit at the time, thereby forming GABAB receptors containing KCTD 
homomers (Metz et al., 2011). 
Interestingly, additional proteins are recruited to GABAB receptors by linkage through KCTD16 or KCTD8. 
One of them is synaptotagmin 11 (Syt11), which was found in the interactome of GABAB receptors and 
specifically enriched in GABAB‐ and KCTD16‐specific affinity purifications (Schwenk et al., 2016). Recently, 
the KCTD16‐Syt11 interaction was confirmed in co‐immunoprecipitation experiments (Y. Tan, personal 
communication). This might be relevant for presynaptic function, as other members of the 
synaptotagmin protein family are crucial for synaptic release (Südhof, 2014). Conceivably, GABAB 
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receptors, KCTD16, Syt11 and N‐type VGCCs all form a large protein complex. In this putative complex, 
KCTD16 recruits both Syt11 and N‐type‐VGCCs simultaneously to the GABAB receptor. The precise role of 
Syt11 in such a complex is not clear a priori, as not much is known about its function. Given the low 
calcium‐affinity of Syt11 (von Poser et al., 1997), a calcium sensor function similar to what was 
demonstrated for other synaptotagmins is rather unlikely, but cannot be excluded completely, because 
physical proximity of Syt11 and N‐type VGCCs might still enable calcium sensing. However, in contrast to 
other synaptotagmin proteins, Syt11 was recently demonstrated to be an inhibitor of clathrin‐mediated 
and bulk endocytosis and to have no effect on exocytosis (Wang et al., 2016). Based on this novel finding, 
Wang et al. argue that Syt11 plays an important role in the recycling of synaptic vesicles in neurons. 
For these reasons, Syt11 should be especially important in sustained synaptic neurotransmission, as the 
recycling of synaptic vesicles is becoming more relevant in phases of heightened neuronal activity. 
Through a connection to Syt11, GABAB receptors might be able to disinhibit vesicle endocytosis, in 
addition to the known inhibitory effect on presynaptic vesicle release through Gβγ inhibition of N‐type 
VGCCs (Zamponi and Currie, 2013). 
The results from a recent proteomics study also point towards interactions of the dipeptidyl peptidases 6 
and 10 (DPP6, DPP10) with the GABAB receptor, a role for KCTDs in these connections was suggested but 
has still to be clarified (Schwenk et al., 2016). DPP6 and DPP10 are reported to be relevant for 
modulation of potassium channels, but do not seem to possess any peptidase activity despite exhibiting 
homologies to other peptidases (Nadal et al., 2003, Jerng et al., 2005, Kaulin et al., 2009). At the 
moment, not much is known about the function of DPPs in GABAB signaling, so further studies are 
needed to elucidate the relevance of DPP6 and DPP10 for GABAB receptors. 
In a broader perspective, GABAB receptors are not only connected to other signaling complexes through 
their auxiliary KCTD subunits, but also interact with a variety of other proteins through direct binding to 
the principal GABAB receptor complex, particularly to GABAB1 or specific G proteins (Fig. 17). One 
category consists of transmembrane proteins such as the amyloid β A4 protein (APP), the amyloid‐like 
protein 2 (APLP2) and the adherens junction‐associated protein 1 (AJAP1) (Schwenk et al., 2016). These 
proteins mainly interact with the GABAB receptor through binding to the extracellular sushi domains of 
GABAB1a (Schwenk et al., 2016). Some of them likely have a function in axonal trafficking of GABAB 
receptors. Another category of interactors is composed by different proteins that directly interact with 
the intracellular C‐terminus of GABAB1. These proteins include regulatory proteins like 14‐3‐3 proteins 
(Couve et al., 2001, Brock et al., 2005), the capsaicin receptor TRPV1 (Hanack et al., 2015) as well as the 
synaptic protein syntaxin‐1 (see Fig. 14). Other GABAB interactors such as regulator of G protein signaling 
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7 (RGS7) and the Gα inhibitory interacting protein GINIP directly bind and modulate G proteins (Fajardo‐
Serrano et al., 2013, Gaillard et al., 2014). Furthermore, there are several proteins in the GABAB 
interactome, for which the interactions with the GABAB receptor complex are poorly described at the 
moment. These include membrane proteins like the previously mentioned DPPs, the neuronal adhesion 
molecule neuroligin‐3, the PILR‐associating neural protein (PIANP), the integral membrane proteins 
(ITM2B/C) and endoplasmatic reticulum proteins such as Reticulocalbin 2 and Calnexin (Schwenk et al., 
2016). The functional consequences of these protein‐protein interactions will also have to be elucidated, 
in order to gain a more complete understanding of GABAB receptor physiology and signaling. 
Figure 17. Several constituents of the GABAB receptor complex mediate the biochemical connections 
to peripheral GABAB interactors. KCTD16 serves as a scaffold for peripheral GABAB interactors such as 
HCN2 and CaV2.2 channels, Syt11, 14‐3‐3s and Cul3. Several proteins (APP, AJAP1, APLP2) specifically 
interact with the Sushi domains of GABAB1a. Another group of proteins (14‐3‐3s, syntaxin‐1, TRPV1) is 
binding to the intracellular C‐terminus of the GABAB1 subunit. Some interactors such as RGS7 and GINIP 
directly bind G proteins and modulate their signaling. Several interactions remain to be described in 
more detail (dashed lines). 
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So far, KCTD proteins have been implicated in several diverse biological processes. As might be 
anticipated given their possession of a potassium channel tetramerization domain, some KCTDs are 
known to play a role in the regulation of potassium ion channels, e.g. overexpression of the potassium 
channel regulatory protein (KCNRG) was shown to strongly inhibit potassium currents (Ivanov et al., 
2003). KCNRG was also postulated as a cancer suppressor protein (Ivanov et al., 2003). However, not all 
KCTDs control potassium currents in this manner, as KCTD5 was shown not to affect potassium currents 
(Dementieva et al., 2009). KCTD1 was shown to be a regulator of transcription of AP‐2α (Ding et al., 
2009). KCTDs also control proliferation and apoptosis (Birerdinc et al., 2009), play roles in DNA 
replication (Zhou et al., 2005, Yang et al., 2009) and are essential for mitosis (Kittler et al., 2007). In 
agreement with KCTDs being substrate adaptors of CRL3 complexes, KCTD11 ubiquitinates and degrades 
HDAC1, thereby down‐regulating hedgehog‐signaling and suppressing tumors (Canettieri et al., 2010, 
Correale et al., 2011). Similarly, the KCTD subfamily of BACURDs regulate RhoA signaling by promoting 
ubiquitination and subsequent degradation of RhoA (Chen et al., 2009).  
It will also be interesting to see whether GPCR‐related functions solely exist for the subfamily of GABAB 
receptor‐associated KCTDs or whether other members of the KCTDs family also associate with GPCRs. 
Interestingly, different KCTD proteins were identified in tandem affinity purifications of individual G 
proteins, KCTD5 was found to be associated with Gβ2 and likewise KCTD2 and KCTD5 interact with Gγ2 
(Ahmed et al., 2010). Involvement in GPCR physiology was also found in proteins similar to the KCTDs. 
E.g. the Kelch‐like protein 12 (KLHL12), which also belongs to the BTB protein superfamily, was found to 
be ubiquitinating and degrading dopamine D4 receptors, by functioning as a substrate adaptor for CRL3 
complexes (Rondou et al., 2008). 
In this work, the biological functions of the KCTD protein family are further extended, with the addition 
of important GABAB scaffolding functions to two downstream signaling complexes and the unexpected 
discovery of novel interactors of CRL3 complexes. This role for KCTDs opens a wide range of new 
regulation mechanisms for GABAB receptors as well as their linked signaling complexes. Furthermore, the 
results of this work have important implications for the modulation of presynaptic neurotransmission by 
GABAB receptors. 
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Stabilization of neuronal activity by homeostatic control systems is
fundamental for proper functioning of neural circuits. Failure in
neuronal homeostasis has been hypothesized to underlie common
pathophysiological mechanisms in a variety of brain disorders.
However, the key molecules regulating homeostasis in central
mammalian neural circuits remain obscure. Here, we show that
selective inactivation of GABAB, but not GABAA, receptors impairs
firing rate homeostasis by disrupting synaptic homeostatic plastic-
ity in hippocampal networks. Pharmacological GABAB receptor
(GABABR) blockade or genetic deletion of the GB1a receptor sub-
unit disrupts homeostatic regulation of synaptic vesicle release.
GABABRs mediate adaptive presynaptic enhancement to neuronal
inactivity by two principle mechanisms: First, neuronal silencing
promotes syntaxin-1 switch from a closed to an open conformation
to accelerate soluble N-ethylmaleimide-sensitive factor attachment
protein receptor (SNARE) complex assembly, and second, it boosts
spike-evoked presynaptic calcium flux. In both cases, neuronal inactiv-
ity removes tonic block imposed by the presynaptic, GB1a-containing
receptors on syntaxin-1 opening and calcium entry to enhance proba-
bility of vesicle fusion. We identified the GB1a intracellular domain
essential for the presynaptic homeostatic response by tuning in-
termolecular interactions among the receptor, syntaxin-1, and the
CaV2.2 channel. The presynaptic adaptations were accompanied
by scaling of excitatory quantal amplitude via the postsynaptic,
GB1b-containing receptors. Thus, GABABRs sense chronic pertur-
bations in GABA levels and transduce it to homeostatic changes in
synaptic strength. Our results reveal a novel role for GABABR as a
key regulator of population firing stability and propose that dis-
ruption of homeostatic synaptic plasticity may underlie seizure’s
persistence in the absence of functional GABABRs.
homeostatic plasticity | GABAB receptor | synaptic vesicle release |
syntaxin-1 | FRET
Neural circuits achieve an ongoing balance between plasticityand stability to enable adaptations to constantly changing
environments while maintaining neuronal activity within a stable
regime. Hebbian-like plasticity, reflected by persistent changes in
synaptic and intrinsic properties, is crucial for refinement of
neural circuits and information storage; however, alone it is
unlikely to account for the stable functioning of neural networks
(1). In the last 2 decades, major progress has been made toward
understanding the homeostatic negative feedback systems un-
derlying restoration of a baseline neuronal function after pro-
longed activity perturbations (2–4). Homeostatic processes may
counteract the instability by adjusting intrinsic neuronal excit-
ability, inhibition-to-excitation balance, and synaptic strength via
postsynaptic or presynaptic modifications (5, 6) through a pro-
found molecular reorganization of synaptic proteins (7, 8). These
stabilizing mechanisms have been collectively termed homeo-
static plasticity. Homeostatic mechanisms enable invariant firing
rates and patterns of neural networks composed from in-
trinsically unstable activity patterns of individual neurons (9).
However, nervous systems are not always capable of maintain-
ing constant output. Although some mutations, genetic knockouts,
or pharmacologic perturbations induce a compensatory response
that restores network firing properties around a predefined “set
point” (10), the others remain uncompensated, or their compen-
sation leads to pathological function (11). The inability of neural
networks to compensate for a perturbation may result in epilepsy
and various types of psychiatric disorders (12). Therefore, de-
termining under which conditions activity-dependent regulation
fails to compensate for a perturbation and identifying the key re-
gulatory molecules of neuronal homeostasis is critical for under-
standing the function and malfunction of central neural circuits.
In this work, we explored the mechanisms underlying the
failure in stabilizing hippocampal network activity by combining
long-term extracellular spike recordings by multielectrode arrays
(MEAs), intracellular patch-clamp recordings of synaptic responses,
imaging of synaptic vesicle exocytosis, and calcium dynamics, to-
gether with FRET-based analysis of intermolecular interactions at
individual synapses. Our results demonstrate that metabotropic, G
protein-coupled receptors for GABA, GABABRs, are essential for
firing rate homeostasis in hippocampal networks. We explored the
mechanisms by which GABABRs gate homeostatic synaptic
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plasticity. Our study raises the possibility that persistence of
epileptic seizures in GABABR-deficient mice (13–15) is directly
linked to impairments in a homeostatic control system.
Results
GABABR Blockade Disrupts Firing Rate Homeostasis. Mice lacking
functional GABABRs because of GB1 or GB2 subunit deletion
display continuous spontaneous seizure activity (13–16). These
findings are quite counterintuitive in light of a wide range of G
protein-coupled receptors that mediate synaptic inhibition and
might compensate for GABABR loss of function. Therefore, we
hypothesized that functional GABABRs may play an essential
role in neuronal homeostasis. To test this hypothesis, we exam-
ined homeostasis of mean firing rate of a neuronal population
after chronic blockade of GABABRs. To chronically monitor
neuronal activity in stable neural populations, we grew hippo-
campal cultures on MEAs for ∼3 wk. Each MEA contains 59
recording electrodes, with each electrode capable of recording
the activity of several adjacent neurons (Fig. 1A). Spikes were
detected and analyzed using principal component analysis to
obtain well-separated single units that were consistent throughout
at least 2 d of recording (SI Appendix, Methods). To assess how
chronic inhibition of the basal GABABR activity affects mean
firing rate of neural network, we measured spiking activity during
a baseline recording period and for 2 d after application of
CGP54626 (CGP), a selective GABABR antagonist. Fig. 1B il-
lustrates raster plots during periods of baseline, 1 h, and 48 h after
1 μMCGP application in a single experiment. Indeed, CGP causes
an acute increase of 67 ± 13% in the mean firing rate (Fig. 1C),
confirming proconvulsive properties of GABABR antagonists in
vivo (17). However, to our surprise, mean firing rate was not
normalized during 2 d in the constant presence of CGP. After 2 d,
firing rate remained 67 ± 18% higher in the presence of GABABR
antagonist (P < 0.01; Fig. 1C). Notably, under control conditions,
network spike rates were stable during the 2 d of recording (no
treatment, P > 0.2 between 1 h and 48 h; Fig. 1D).
To confirm that the lack of firing rate homeostasis is specific
to the GABABR blockade, we examined how chronic blockade
of GABAARs affects the population firing rate in hippocampal
networks. Application of GABAAR antagonist gabazine (30 μM)
caused a fast and pronounced increase in the population firing
rate to 330 ± 32%, which gradually declined over the course of
2 d in the presence of gabazine (Fig. 1E), despite the constant
presence of the antagonist. Washout of gabazine after 2 d caused
a significant decrease in firing rate, indicating sustained activity
of both gabazine and the GABAARs (SI Appendix, Fig. S1).
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Fig. 1. GABABR blockade disrupts firing rate homeostasis in hippocampal networks. (A, Left) Image of MEA dish. (Middle) Image of dissociated hippocampal culture
plated on MEA. Black circles at the end of the black lines are the recording electrodes. (Right) Representative traces of recording from four MEA channels (a, b, c, and d).
(B) Representative raster plot of MEA recording before and 1 and 48 h after application of the GABABR antagonist CGP (1 μM). (C–F) Mean firing rate of hippocampal
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Moreover, a GABABR agonist, baclofen, triggered a pronounced
block of firing rate that was precisely restored to the baseline level
after a period of 2 d (9). The observed compensatory responses to
increase in spiking activity by GABAAR antagonist or decrease in
spiking activity by GABABR agonist confirm the idea that ho-
meostatic mechanisms maintain stable circuit function by keep-
ing neuronal firing rate around a “set point” (10, 18).
Given a 3.4-fold difference in the magnitude of the initial firing
rate increase produced by GABAAR versus GABABR blockade, it
is plausible that the lack of firing rate renormalization in the
presence of CGP was a result of its relatively weak effect on firing
rate. If this is the case, concurrent blockade of GABAARs and
GABABRs would result in a reversal of firing rate, as in the
presence of the GABAAR blocker alone. However, coapplication
of gabazine and CGP triggered an initial increase in firing rate by
416 ± 61% that remained at 415 ± 63% for 2 d in the presence of
the GABAR blockers (P < 0.001; Fig. 1F), suggesting selective
GABABR blockade truly disrupts firing rate renormalization. Al-
together, these results demonstrate that ongoing GABABR activity
is required for firing rate homeostasis in hippocampal networks.
GB1a-Containing GABABRs Mediate Homeostatic Increase in Evoked
Vesicle Release. What are the mechanisms underlying disruption
of firing rate homeostasis by GABABR blockade? To address
this question, we assessed the dependency of synaptic homeo-
static responses that normally contribute to firing rate homeostasis
on the GABABR function during activity changes. As a pertur-
bation, we applied tetrodotoxin for 48 h (TTX48h) to silence
spiking activity, a classical paradigm in homeostasis research. First,
we asked whether active GABABRs are required for inactivity-
induced increase in spike-evoked vesicle exocytosis estimated by
the FM1-43 method (19). To this end, the total pool of recycling
vesicles was stained by maximal stimulation (600 stimuli at 10 Hz)
and subsequently destained by 1 Hz stimulation (Fig. 2A and SI
Appendix, Fig. S2A). TTX48h induced a 1.4-fold increase in the
destaining rate constant (measured as 1/τdecay, whereas τdecay is an
exponential time course) and, thus, vesicle exocytosis (P < 0.001;
Fig. 2 B and G). However, the adaptive enhancement of release
probability (Pr) to inactivity was abolished when neurons were
treated with TTX in the presence of CGP over the course of 48 h
[(TTX + CGP)48h; P > 0.4; Fig. 2 C and G]. Importantly, CGP
application acutely increased FM destaining rate (P < 0.01; SI
Appendix, Fig. S2B), which remained elevated for 48 h in the
presence of CGP (CGP48h; P < 0.01; Fig. 2 C and G), indicating
that the expected compensatory reduction in Pr was impaired
under the GABABR blockade. Acute application of CGP after
TTX48h treatment during FM destaining did not alter adaptive
increase in vesicle exocytosis (SI Appendix, Fig. S2C). It is note-
worthy that Pr was not saturated under GABABR blockade, as
presynaptic homeostatic compensation by TTX48h was normally
expressed in high-Pr boutons under elevated extracellular Ca2+
levels (Fig. 2 D and G and SI Appendix, Fig. S2D). Moreover,
GABAAR blockade by gabazine for 48 h induced an adaptive
reduction in Pr that was prevented by CGP coapplication (SI
Appendix, Fig. S3). Thus, the failure in the homeostatic mecha-
nisms is not associated with modulation of basal Pr. Taken
together, these results indicate that basal GABABR activity is
necessary to achieve a compensatory increase in spike-evoked
synaptic vesicle exocytosis in hippocampal synapses.
Which isoform of the GABABRs mediates homeostatic in-
crease in evoked vesicle release? GABABRs are obligatory het-
erodimers, requiring two homologous subunits, GB1 and GB2, for
functional expression (20). In hippocampal synapses, the GB1a
isoform is predominantly expressed at glutamatergic presynaptic
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boutons, whereas GB1b is predominantly expressed at spines (21).
Thus, we examined whether the presynaptic homeostatic response
is disrupted in 1a−/− boutons lacking the GB1a receptor subunit
(21). The 1a−/− boutons did not display a presynaptic response to
activity blockade (Fig. 2 E and G). The deficits in presynaptic
homeostatic plasticity were specific for the GB1a isoform, as 1b
−/−
boutons displayed a typical adaption to prolonged synaptic in-
activity (Fig. 2 F and G). Notably, acute application of CGP in-
creased evoked synaptic vesicle release in the wild-type and 1b−/−,
but not 1a−/−, boutons (SI Appendix, Fig. S4), confirming that the
GB1a-containing receptors mediate inhibition of Pr by local
GABA levels. Although our previous data demonstrated a cor-
relation between inactivity-induced reduction in the GB1a re-
ceptor activity and increase in Pr (22), our current results suggest
that the basal GB1a receptor activity is required for homeostatic
Pr regulation (Fig. 2H).
In contrast to inactivity-induced regulation of spike-evoked
vesicle exocytosis, neither acute (SI Appendix, Fig. S5) nor chronic
(SI Appendix, Fig. S6) application of CGP affected miniature
excitatory postsynaptic current (mEPSC) frequency. Moreover,
TTX48h alone or in the presence of CGP48h did not significantly
change mEPSC frequency (SI Appendix, Fig. S6). It is worth
mentioning that TTX48h reduced short-term synaptic facilitation
during spike bursts measured by double-patch recordings (SI
Appendix, Fig. S7), indicating an increase in Pr (23). Thus, the
difference between spike-evoked and spontaneous vesicle release
regulation observed under our experimental conditions reflects
differential regulation of exocytosis during spontaneous and
evoked synaptic activity (24). Although GABABR blockade did
not affect regulation of mEPSC frequency, it impaired inactivity-
induced increase in mEPSC amplitude, suggesting the post-
synaptic GABABRs are involved in this regulation. Indeed,
the effect of TTX48h was absent in 1b
−/− neurons (SI Appendix,
Fig. S8), suggesting the GB1b-containg postsynaptic GABABRs
play an important role in synaptic scaling.
Inactivity Promotes Syntaxin-1 Conformational Switch.What are the
molecular mechanisms underlying the homeostatic increase in Pr
by presynaptic GABABRs? SNARE-complex assembly is initi-
ated by a syntaxin-1 (Synt1) switch from its closed conformation
(in which the N-terminal Habc domain of Synt1 folds back onto its
SNARE domain) into an open conformation (in which the
SNARE domain becomes unmasked for SNARE-complex for-
mation) (25). Rendering Synt1 constitutively open induces an in-
crease in Pr by enhancing SNARE-complex assembly per vesicle
(26). However, activity-dependent mechanisms regulating Synt1
conformational switch are not fully understood.
To assess whether chronic inactivity promotes Synt1 opening,
we used a recently developed intramolecular Synt1a FRET probe
(CFP-Synt1a-YFP) that reports the closed-to-open transition as a
decrease in FRET efficiency (27). The Synt1a sensor contains
CFP fluorophore inserted at the N terminus and YFP inserted
after the SNARE motif (Fig. 3A) and is well expressed in pro-
cesses of hippocampal neurons (Fig. 3B). The engineered Synt1a
FRET reporter has been shown to assemble into endogenous
SNARE complexes and was able to reconstitute dense-core
vesicle exocytosis in PC12 cells (27). Furthermore, we show that
neurons transfected with the light chain of BoNT-C1 are not
capable of synaptic vesicle recycling, even during strong stimu-
lation (600 pulses at 20 Hz; Fig. 3C). However, coexpression of
BoNT-C1, together with BoNT-C1-insensitive CFP-Synt1aK253I-
YFP mutant reporter, restores synaptic vesicle recycling to the
level observed in wild-type neurons (Fig. 3C). These results
strongly suggest the CFP-Synt1a-YFP FRET reporter is functional,
supporting synaptic vesicle exocytosis in hippocampal neurons.
To monitor Synt1a conformational changes, we measured the
steady-state FRET efficiency (Em), using the acceptor photo-
bleaching method at presynaptic boutons expressing CFP-Synt1a-YFP
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(Fig. 3B, 2 and 3). High-magnification confocal images show an
increase in CFP fluorescence after YFP photobleaching (Fig.
3D), indicating dequenching of the donor and the presence of
FRET. On average, CFP-Synt1a-YFP FRET efficiency across
hippocampal boutons was 0.12 ± 0.02 (Fig. 3E). To validate that
the probe reports closed-to-open transition as a decrease in FRET
efficiency, we used the Synt1a
Open FRET probe with L165E/L166E
mutations, rendering Synt1 in a constitutively open conformation
(25). Indeed, Synt1a
Open displayed 56% lower FRET efficiency in
comparison with the wild-type Synt1a probe (0.053 ± 0.01; P <
0.01; Fig. 3E).
Next, we asked whether Synt1a conformation is homeostatically
regulated by chronic neuronal inactivity to promote Pr augmen-
tation. Indeed, TTX48h induced a reduction in Synt1a FRET to
0.05 ± 0.01 (P < 0.01; Fig. 3F). Notably, the reduction magnitude
by TTX48h was similar to that exhibited by Synt1a
Open and was
occluded by Synt1a
Open. At the functional level, Synt1a
Open in-
creased the rate of vesicle exocytosis (P < 0.05; Fig. 3G), supporting
results of earlier studies (26, 28). Most important, Synt1a
Open
occluded the effect of TTX48h on Pr (P > 0.7; Fig. 3G), sug-
gesting a functional importance of Synt1a opening in compen-
satory Pr augmentation.
Removal of GABABR Block Mediates Inactivity-Induced Syntaxin-1
Opening. To examine whether GABABR tone is required for
inactivity-induced Synt1a opening, we first asked whether Synt1a
conformation is regulated by basal GABABR activity. Acute
application of GABABR antagonist CGP reduced mean FRET
level to 0.048 ± 0.01 (P < 0.01; Fig. 4A). Application of
GABABR agonist baclofen (10 μM) did not affect FRET (P >
0.05; Fig. 4A), indicating that basal GABA levels are sufficient to
stabilize a closed Synt1a conformation. Next, we asked whether
GABABR blockade interferes with TTX48h-induced Synt1a
opening. CGP48h caused a reduction in Synt1a FRET (P < 0.01;
Fig. 4B) and occluded the effect of TTX48h on Syn1a confor-
mational change (Fig. 4B). The effect of CGP48h was mimicked
by deletion of the GB1a receptor subunit: Synt1a FRET was two-
fold lower in 1a−/− boutons and insensitive to chronic reduction in
spiking activity by TTX48h (Fig. 4B). Importantly, acute applica-
tion of baclofen restored Synt1a FRET in TTX48h-treated neurons
(Fig. 4C), suggesting prolonged silencing may promote Synt1a
opening by reducing the extracellular GABA levels (22).
Having established the necessity for GB1a-containing GABABRs
in the homeostatic conformational change of Synt1a, we explored
a possibility of Synt1a and GB1a interactions. To quantify activity-
dependent changes in GB1a–Synt1a interactions at individual
presynaptic sites, we used the FRET approach. To preserve the
functionality of the Synt1a FRET reporter, we replaced CFP by its
nonfluorescent mutant CFP-W66A, and a Cerulean (Cer)-tagged
GB1a subunit at the C terminus (GB1a
Cer) was used as a donor
(Fig. 4D). Basal GB1a
Cer/Synt1a
YFP FRET efficiency was 0.04 ±
0.01 and underwent a 2.4-fold increase by TTX48h (P < 0.01; Fig.
4E). Notably, blockade of GABABRs produced a similar effect
(P < 0.01; Fig. 4E), indicating that GB1a/Synt1a interactions are
regulated by basal GABA. Moreover, CGP48h occluded TTX48h-
induced GB1a
Cer/Synt1a
YFP FRET changes (P = 0.9; Fig. 4E). To
determine the existence of endogenous protein complexes con-
taining Synt1 and GABABRs, we performed coimmunoprecipi-
tation experiments with solubilized mouse brain membranes.
Anti-Synt1 antibodies coprecipitated a significant amount of GB1
proteins together with Synt1 from WT, but not from full GB1-KO
mice (SI Appendix, Fig. S9). Taken together, these results indicate
that Synt1a conformational change constitutes a critical step in
presynaptic homeostatic response, that basal GABABR activity
maintains Synt1a in a closed conformation (Fig. 4F, 1), and that
prolonged inactivity removes a GABABR-imposed clamping of a
closed Synt1a conformation, allowing Synt1a shift toward its open
conformation (Fig. 4F, 2).
GB1a Is Required for Homeostatic Increase in Presynaptic Calcium
Flux. Next, we examined whether the GB1a receptor subunit
controls homeostatic regulation of presynaptic Ca2+ transients (29),
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in addition to regulating Synt1 conformational switch, to adapt Pr
to chronic activity perturbations. Thus, we measured presynaptic
Ca2+ transients evoked by 0.1-Hz stimulation, using high-affinity
fluorescent calcium indicator Oregon Green 488 BAPTA-1 AM
(Fig. 5A) at functional boutons identified by the FM4-64 marker.
Although the size of action-potential dependent fluorescence
transients (ΔF/F) varied between different boutons, presynaptic
Ca2+ flux was significantly larger in TTX48h-treated WT neurons
(P < 0.0001; Fig. 5 A and C). Importantly, presynaptic Ca2+ flux was
higher in boutons of 1a−/− neurons (P < 0.0001; Fig. 5 B and C),
occluding the effect of TTX48h on further potentiation of calcium
transients. It is noteworthy that Ca2+ transients were not saturated
by single action potential in 1a−/− boutons (SI Appendix, Fig. S10).
Furthermore, acute application of CGP increased presynaptic Ca2+
flux that remained stable over the course of 2 d in the presence of
CGP in WT (P < 0.001; Fig. 5 A and D), but not in 1a−/− (P > 0.4;
Fig. 5 B and D), neurons. This lack of compensation at the level of
Ca2+ flux was specific for the GABABR deficit, as GABAAR
blockade by gabazine has been previously shown to trigger an
adaptive reduction in presynaptic Ca2+ transients (29). These re-
sults indicate that GB1a-containing GABABRs normally inhibit
presynaptic Ca2+ flux evoked by single action potential and that
removal of the GABABR-mediated block is essential for ho-
meostatic potentiation of Ca2+ flux by chronic inactivity.
GB1aPCT Mediates Presynaptic Homeostatic Response. Next, we
searched for the molecular domain in the GB1a protein that
mediates the presynaptic homeostatic response. In our previous
work, we identified the proximal C-terminal domain of the GB1a
protein (R857-S877; GB1aPCT; Fig. 6A) as essential for the
compartmentalization of the presynaptic signaling complex of
GABABRs, Gβγ G protein subunits, and CaV2.2 channels in
hippocampal boutons (30). Interestingly, deletion of GB1aPCT
domain specifically impaired CaV2.2/Gβγ interaction and func-
tion, leaving Gαi/o-dependent signaling unaltered.
First, we assessed the functional role of the GB1aPCT domain in
the homeostatic increase of Pr by comparing the effect of TTX48h
on FM4-64 destaining rates in 1a−/− neurons transfected with
GB1aWT-CFP versus GB1aΔPCT-CFP proteins. Expression of the
GB1aWT-CFP protein rescued inactivity-induced potentiation of
vesicle exocytosis in 1a−/− neurons (P < 0.01; Fig. 6 B and D in
comparison with Fig. 2G). In contrast, TTX48h-induced pre-
synaptic enhancement remained impaired in boutons express-
ing GB1aΔPCT-CFP (P > 0.8; Fig. 6 C and D). Moreover,
deletion of the GB1aPCT domain abolished inactivity-induced
increase in presynaptic calcium transients (P > 0.8; Fig. 6 E–G).
Thus, the GB1aPCT domain is necessary for presynaptic adapta-
tions to prolonged inactivity in hippocampal networks.
Finally, we examined whether inactivity induces conformational
GABABR/CaV2.2 changes, and if so, whether the GB1aPCT do-
main is involved in this homeostatic regulation. We monitored
FRET efficiency between the YFP-tagged GB1a receptor subunit
at the C terminus and the CFP-tagged α1 subunit of the CaV2.2
channel at the N terminus (GB1a
YFP/CaV2.2
CFP). TTX48h in-
duced an increase in GB1a
YFP/CaV2.2
CFP FRET (P < 0.05; Fig.
6H), indicating that chronic neuronal silencing alters GB1a/
CaV2.2 interactions. Importantly, deletion of the GB1aPCT domain
disrupted TTX48h-induced homeostatic GB1a
YFP/CaV2.2
CFP
changes (P = 0.49; Fig. 6H). Moreover, GB1aPCT deletion oc-
cluded TTX48h-induced homeostatic GB1a
Cer/GB2
Cit and GB1a
YFP/
Synt1a
CFP changes (SI Appendix, Fig. S11). A physical interaction
between endogenous GABABRs and CaV2.2 was revealed by
coimmunoprecipitation experiments (SI Appendix, Fig. S9), con-
firming previous proteomic data (31). These results suggest that
homeostatic mechanisms modulate GB1a/CaV2.2 and GB1a/Synt1a
interactions in the GABABR presynaptic signaling complex via the
GB1aPCT domain.
Discussion
The ability of neuronal circuits to stabilize their firing properties
in the face of environmental or genetic changes is critical for
normal neuronal functioning. Despite extensive research on a wide
repertoire of possible homeostatic mechanisms, the key regulators
of firing rate homeostasis in mammalian central neural circuits
remain obscure. In this work, we identified the GABABR as a key
homeostatic signaling molecule stabilizing mean firing rate in
hippocampal networks. GABABRs enable inactivity-induced ho-
meostatic increase in synaptic strength by three principle mechanisms:
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promoting synatxin-1 conformational switch to enhance SNARE-
complex assembly, augmenting presynaptic Ca2+ flux to promote
spike-evoked vesicle exocytosis, and increasing the quantal excit-
atory amplitude. Thus, GABABRs, in addition to modulation of
short-term (32, 33) and long-term, Hebbian (21) synaptic plasticity,
are essential for maintaining firing stability of neural circuits.
GABABRs and Synaptic Homeostatic Plasticity. Homeostatic regula-
tion of synaptic strength represents a basic mechanism of neu-
ronal adaptation to constant changes in ongoing activity levels.
Strong evidence exists on homeostatic augmentation of Pr and
readily releasable pool size in response to prolong inactivity in
hippocampal neurons (19, 22, 34–42). These homeostatic adap-
tations are associated with modulation of presynaptic Ca2+ flux
(29) and remodeling of a large number of proteins in presynaptic
cytomatrix (7). Recent studies have identified the mechanisms
underlying presynaptic homeostatic signaling in Drosophila neu-
romuscular junction, implicating epithelial sodium leak channels
(43) and endostatin (44) as homeostatic regulators of the pre-
synaptic CaV2 channels (for review, see ref. 5). However, the
critical molecules controlling presynaptic homeostasis in mam-
malian central synapses are not fully understood.
In this work, we show that chronic neuronal silencing induces
an adaptive increase in evoked basal vesicle release through
GABABRs by removing tonic inhibition of Synt1 conformational
switch and of presynaptic Ca2+ flux. These results are important
for several reasons. First, they reveal a crucial role for GABABRs
in presynaptic homeostasis. Taking into account a wide variety of
G protein-coupled receptors that mediate presynaptic inhibition,
the requirement for the GABABR tone in presynaptic homeo-
static response is particularly striking. Second, they demonstrate,
for the first time, the role of the extracellular GABA in deter-
mining Synt1 conformation via the presynaptic GB1a-containing
GABABRs. Either genetic GB1a deletion or pharmacological
GABABR blockade stabilizes an open Synt1 conformation in
analogy to mutations rendering Synt1 constitutively open, oc-
cluding adaptive response to neuronal silencing. Notably, addi-
tion of GABABR agonist after prolonged inactivity stabilizes a
closed Synt1 conformation, suggesting reduction in local GABA
levels induces an adaptive Synt1a response. Third, in addition to
the well-known role of GABABRs in the presynaptic Ca
2+ flux
inhibition, at a rapid timescale of minutes (22, 45), our work
revealed the necessity for basal GABABR activity in presynaptic
adaptations of Ca2+ transients to chronic activity perturbations at
extended timescales of days. Deletion of the GB1aPCT domain
blocks presynaptic homeostatic plasticity by disrupting GABA-
mediated conformational changes within the presynaptic GB1a/
CaV2.2/Synt1 signaling complex. Thus, endogenous molecular
“brakes” imposed by GABABRs on CaV2.2 channels and SNARE
complex assembly are essential for presynaptic homeostasis in
hippocampal neurons.
It is important to note that in the present study, chronic in-
activity by TTX induced a compensatory increase in mEPSC
amplitude via the postsynaptic GB1b-containing receptors with-
out affecting mEPSC frequency. Given a pronounced effect of
TTX48h on spike-evoked synaptic vesicle exocytosis, these results
suggest complete blockade of spikes does not trigger compen-
satory changes in spontaneous vesicle release. In previous stud-
ies, mEPSC frequency was found to be immune to chronic TTX
treatment in some cases (18, 41), while being up-regulated by
AMPA receptor blockade (36, 41), either by suppression of
neuronal excitability (38) or by increase in the GABABR-medi-
ated inhibition (9). Thus, the induction of presynaptic homeo-
static changes may require minimal spiking activity (41).
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Fig. 6. The GB1aPCT domain is required for presynaptic homeostatic response. (A) Schematics show GB1aWT and GB1aΔPCT constructs. 7TM, seven-trans-
membrane domain; CC, coiled-coiled domain; DCT, distal C-terminal domain; LBD, ligand-binding domain; PCT, proximal C-terminal domain; SD, two sushi do-
mains. (B and C) Representative FM destaining rate curves of 50 synapses pretreated with/without TTX48h in 1a
−/− neurons transfected with GB1aWT (B) or
GB1aΔPCT (C). (D) Expression of GB1aWT (n = 609–642), but not of GB1aΔPCT (n = 598–721), restores presynaptic homeostatic adaptation in 1a−/− neurons. (E and
F) TTX48h did not alter spike-dependent presynaptic Ca
2+ entry in boutons expressing GB1aΔPCT in 1a−/− neurons. Representative images of Ca2+ transients
(average of seven traces) evoked by 0.2-Hz stimulation in boutons of control and TTX48h-treated GB1aΔPCT-expressing boutons (E). Averaged Ca2+ transients in
control (n = 44) and TTX48h (n = 37) conditions (F). (G) Summary of TTX48h effect on Ca
2+ transients in boutons expressing GB1aΔPCT protein (the same data as
in F). (H) Effect of TTX48h on GB1a
YFP/CaV2.2
CFP Em (n = 40–88). Deletion of PCT domain abolishes TTX48h-induced change in GB1a
YFP/CaV2.2
CFP Em (n = 44–55).
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GABABR-Mediated Neuronal Homeostasis and Brain Disorders. It is
tempting to speculate that many distinct neurologic and psychiatric
disorders with different etiologies share common dysfunctions in
pathways related to homeostatic plasticity. However, the molecular
mechanisms by which defective homeostatic signaling may lead to
common disease pathophysiology remain to be determined. Only a
few molecular links, such as the schizophrenia-associated gene
dysbindin, have been established between homeostatic system im-
pairments and brain dysfunctions (46). Our study demonstrates that
ongoing GABABR activity is essential for population firing rate
homeostasis in hippocampal networks. This may explain why ab-
errant neuronal activity remains uncompensated in mice lacking
functional GABABRs as a result of deletion of either the GB1 (13)
or GB2 (15) receptor subunit. Interestingly, 1a
−/−, but not 1b−/−,
mice exhibit spontaneous epileptiform activity (16), suggesting the
presynaptic GB1a-containing receptors may play a more prominent
role in firing rate homeostasis. Strikingly, our results show that
homeostatic plasticity is impaired in synaptic networks displaying
enhanced ongoing synaptic Ca2+ flux because of removal of the
GABABR-mediated block. Thus, CaV2 channel gain of function
may be as detrimental for neuronal homeostasis as CaV2 loss of
function (47, 48), indicating that an optimal level of ongoing syn-
aptic Ca2+ flux may be essential for homeostatic regulation. It re-
mains to be seen whether the loss of functional GABABRs,
associated with epilepsy and a wide range of psychiatric disorders
(49), contributes to pathophysiology shared by these disorders
through erasing critical pathways in homeostatic control systems.
Materials and Methods
Hippocampal Cell Culture. Primary cultures of CA3-CA1 hippocampal neurons
were prepared from WT, 1a−/−, and 1b−/− (BALB/c background) mice (21) on
postnatal days 0–2, as described (50). The experiments were performed in
mature (14–28 d in vitro) cultures. All animal experiments were approved by
the Tel Aviv University Committee on Animal Care.
MEA Preparation and Recordings. Cultures were plated on MEA plates con-
taining 59 TiN recording and one internal reference electrodes [Multi Channel
Systems (MCS)]. Electrodes are 30 μm in diameter and spaced 500 μm apart.
Data were acquired using a MEA1060-Inv-BC-Standard amplifier (MCS) with
frequency limits of 5,000 Hz and a sampling rate of 10 kHz per electrode
mounted on an Olympus IX71 inverted microscope. Recordings were carried
out under constant 37 °C and 5% CO2 conditions, identical to incubator con-
ditions. Spike sorting and analysis are described in ref. 9 and in SI Appendix,
Spike Sorting and Data Analysis.
Molecular Biology. GB1aWT-, GB1aΔPCT-, GB2-, and CaV2.2-tagged proteins
used throughout the study were constructed as described before (30). Synt1a
(CSYS-5RK), Synt1a
Open, and Synt1aK253I are as described in ref. 27. W66A
point mutation was introduced to silence YFP in the YFP-Synt1a-CFP con-
struct (Fig. 4 D and E and SI Appendix, Fig. S11). BoNT/C1α-51-IRES-EGFP was
designed and then generated by ProGen Israel, Protein and Gene Engi-
neering Company. Transient cDNA transfections have been performed using
Lipofectamine-2000 reagents, and neurons were typically imaged 18–48 h
after transfection.
Estimation of Synaptic Vesicle Release Using FM Dyes. Activity-dependent
FM1-43 or FM4-64 styryl dyes have been used to estimate synaptic vesicle
exocytosis and presynaptic plasticity, as described (22). The experiments were
conducted at room temperature in extracellular Tyrode solution containing
(in mM): NaCl, 145; KCl, 3; glucose, 15; Hepes, 10; MgCl2, 1.2; CaCl2, 1.2, with
pH adjusted to 7.4 with NaOH. The extracellular medium contained non-
selective antagonist of ionotropic glutamate receptors (kynurenic acid,
0.5 mM) to block recurrent neuronal activity. Synaptic vesicles were loaded
with 15 μM FM4-64 in all of the experiments with GFP/CFP/YFP transfection,
whereas 10 μM FM1-43 was used in all of the nontransfected neurons.
Detecting Presynaptic Calcium Transients. Fluorescent calcium indicator Oregon
Green 488 BAPTA-1 AM was dissolved in DMSO to yield a concentration of
1 mM. For cell loading, cultures were incubated at 37 °C for 30 min with 3 μM
of this solution diluted in a standard extracellular solution. Imaging was
performed using FV1000 Olympus confocal microscopes, under 488 nm
(excitation) and 510–570 nm (emission), using 500-Hz line scanning.
FRET Imaging and Analysis. Intensity-based FRET imaging was carried as de-
scribed before (22, 30). Donor dequenching resulting from the desensitized
acceptor was measured from Cer/CFP emission (460–500 nm) before and
after the acceptor (YFP) photobleaching. Mean FRET efficiency, Em, was then
calculated using the equation Em = 1 − IDA/ID, where IDA is the peak of donor
emission in the presence of the acceptor and ID is the peak after acceptor
photobleaching.
Statistical Analysis. Error bars shown in the figures represent SEM. Where
applicable, the number of experiments (cultures) or the number of boutons is
defined by n. All the experiments were repeated at least in three different
batches of cultures. One-way ANOVA analysis with post hoc Bonferroni’s
was used to compare several conditions. Student’s unpaired, two-tailed
t test has been used in the experiments in which two different populations
of synapses were compared. Student’s paired, two-tailed t test has been used
in the experiments where before and after treatments were compared at
the same population of synapses. *P < 0.05; **P < 0.01; ***P < 0.001; ns,
nonsignificant.
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Materials and Methods 
Hippocampal cell culture. Primary cultures of CA3-CA1 hippocampal neurons were prepared from 
WT, 1a–/–, and 1b–/– (BALB/c background) mice on postnatal days 0–2, as described (1). The 
generation of the 1a–/– and 1b–/– mice has been described previously (2). The experiments were 
performed in mature (13 - 28 days in vitro) cultures. All animal experiments were approved by the 
Tel Aviv University Committee on Animal Care.  
MEA preparation and recordings. Cultures were plated on MEA plates containing 59 TiN 
recording and one internal reference electrodes (Multi Channel Systems (MCS)). Electrodes are 30 
µm in diameter and spaced 500 µm apart. Data was acquired using a MEA1060-Inv-BC-Standard 
amplifier (MCS) with frequency limits of 5000 Hz and a sampling rate of 10 kHz per electrode 
mounted on an Olympus IX71 inverted microscope. Recordings were carried out under constant 37Ԩ 
and 5% CO2 conditions, identical to incubator conditions.  
Spike sorting and data analysis. Raw data was filtered, offline, at 200 Hz using a Butterworth high-
pass filter. Spikes cutouts were then detected, offline, using MC Rack software (MCS) based on a 
fixed threshold set to between 4-5 standard deviations from noise levels as described (3). To reduce 
processing time, only the first twenty minutes of each hour were used for analysis. Spike cutouts were 
then transferred to Offline Sorter (Plexon Inc.) for spike sorting. Spikes were plotted in 2-D or 3-D 
principal component (PC) space and unit clusters were semi-automatically detected using K-means 
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clustering algorithm followed by template sorting. Clusters were then manually inspected to insure 
stability throughout experiment. All analysis was performed using custom-written scripts in 
MATLAB (Mathworks). Network mean firing rates were calculated by averaging the mean firing 
rates of all units for a given time-point.  
Whole-cell recordings in hippocampal culture. Experiments were performed at room temperature 
in a recording chamber on the stage of FV300 inverted confocal microscope. Extracellular Tyrode 
solution contained (in mM): NaCl, 145; KCl, 3; glucose, 15; HEPES, 10; MgCl2, 1.2; CaCl2, 1.2; pH 
adjusted to 7.4 with NaOH. mEPSCs were recorded using the following intracellular solution (in 
mM): Cs-MeSO3, 120; HEPES, 10; NaCl, 10; CaCl2, 0.5; Mg2+-ATP, 2; Na3GTP, 0.3; EGTA, 10; pH 
adjusted to 7.25 with NaOH. Serial resistance was not compensated. For mEPSCs recordings, 
Tetrodotoxin (TTX; 1 M), amino-phosphonopentanoate (AP-5; 50 M), and gabazine (30 M) were 
added to the Tyrode solution. Access resistance was between 5 - 10 M. Neurons were excluded 
from the analysis if RMP was > - 55 mV, serial resistance was > 10 M or if any of these parameters 
changed by >20% during the recording.  
Dual whole-cell perforated patchclamp recordings were made on two inter-connected cultured 
hippocampal pyramidal neurons. Perforated patch pipettes were front filled with a solution containing 
CsOH, 127 mM; D-gluconic acid, 127 mM; CsCl, 4 mM; HEPES, 10 mM; NaCl, 8 mM; and EGTA, 
0.4 mM; pH was adjusted to 7.25 with CsOH and then back filled with the same solution containing 
150–200 ng/ml amphotericin B. The presynaptic cell was stimulated by 1 ms step depolarization from 
-70 to +30 mV in voltage-clamp mode. The postsynaptic cells were held in voltage-clamp at -70 mV. 
Only neurons with monosynaptic connections were used. The access resistances of both pre- and 
postsynaptic neurons were monitored online and were typically 7–20 MΩ. Recordings with access 
resistance > 20 MΩ or that varied substantially were rejected from analysis.  
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Signals were recorded using a MultiClamp 700B amplifier, digitized by DigiData1440A (Molecular 
Devices) at 10 kHz, and filtered at 2 kHz. mEPSCs were analyzed using MiniAnalysis (Synaptosoft), 
evoked EPSC using pClamp10 (Molecular Devices). For comparison of mEPSC amplitude or 
frequency under different conditions, 200 mEPSCs were randomly selected for each cell and pooled 
for each condition.  
Molecular biology. GB1aWT, GB1aPCT, GB2 and CaV2.2 tagged proteins used throughout the study 
were constructed as described before (4). Syt1a (CSYS-5RK), Syt1aOpen and Syt1a-K253I as described 
in (5). W66A point mutation was introduced to silence YFP in the YFP-Synt1a-CFP construct (Fig. 
4D-E and SI Appendix, Fig. S11). BoNT/C1α-51-IRES-EGFP was designed and then generated by 
ProGen Israel, Protein and Gene Engineering Company. BoNT/C1α-51, triple mutant BoNT/C1 light 
chain (shown to cleave Syntaxin and spare SNAP-25; a kind gift from Meyer Jackson (6)), flanked 
by HindIII and EcoRI sites was cloned into the N-terminus of Internal Ribosome Entry Site (IRES) 
cDNA sequence followed by an EGFP, in PCDNA3. Transient cDNA transfections have been 
performed using Lipofectamine-2000 reagents and neurons were typically imaged 18-48h after 
transfection.  
Estimation of synaptic vesicle release using FM dyes. Activity-dependent FM1-43 or FM4-64 
styryl dyes have been used to estimate synaptic vesicle exocytosis and presynaptic plasticity. Action 
potentials have been elicited by passing 50 mA constant current for 1 ms (~50% above the threshold 
for eliciting action potential) through two platinum wires, separated by ~7 mm and close to the surface 
of the coverslip. The experiments were conducted at room temperature in extracellular Tyrode 
solution contained (in mM): NaCl, 145; KCl, 3; glucose, 15; HEPES, 10; MgCl2, 1.2; CaCl2, 1.2; pH 
adjusted to 7.4 with NaOH. The extracellular medium contained non-selective antagonist of 
ionotropic glutamate receptors (kynurenic acid, 0.5 mM) to block recurrent neuronal activity. 
Synaptic vesicles were loaded with 15 μM FM4-64 in all the experiments with GFP/CFP/YFP 
transfection, while 10 μM FM1-43 was used in all the non-transfected neurons. FM was loaded by 
4 
 
bathing the cultures in a medium containing dye. FM was present 5 sec before and 30 sec after the 
electrical stimulation. After dye loading, external dye was washed away in Ca2+-free solution 
containing ADVASEP-7 (0.1 mM) to scavenge membrane-bound FM. The fluorescence of individual 
synapses was determined from the difference between images obtained after staining and after 
destining (F). To estimate vesicle release during low frequency stimulation, we quantified FM 
destaining rate during 1 Hz stimulation following staining of boutons by maximal stimulation of 600 
action potentials at 20 Hz (7, 8).  
Images were obtained with an Olympus (FV300 or FV1000) confocal laser inverted microscopes. 
The 488-nm line of an argon laser was used for excitation, and the emitted light was filtered using a 
510-nm long-pass filter and detected by a photomultiplier. A 60  1.2 NA water-immersion objective 
was used for imaging. The confocal aperture was partially open and image resolution was 57 - 92 nm 
/ pixel. The gain of the photomultiplier was adjusted to maximize the signal-to-noise ratio without 
causing saturation by the strongest signals. The image after FM dye unloading was subtracted from 
the initial image; thus, only those terminals containing activity-dependent releasable FM dye (~90% 
of total staining) were analyzed. For detection of FM+ puncta, F images have been analyzed (only 
the puncta exhibiting  90% destaining were subjected to analysis) as described before (7).  
Detecting presynaptic calcium transients. Fluorescent calcium indicator Oregon Green 488 
BAPTA-1 AM was dissolved in DMSO to yield a concentration of 1 mM. For cell loading, cultures 
were incubated at 37 C for 30 min with 3 M of this solution diluted in a standard extracellular 
solution. Imaging was performed using FV1000 Olympus confocal microscopes, under 488 nm 
(excitation) and 510 - 570 nm (emission), using 500 Hz line scanning.  
FRET imaging and analysis. Intensity-based FRET imaging was carried as described before (4, 8). 
Donor dequenching due to the desensitized acceptor was measured from Cer/CFP emission (460-500 
nm) before and after the acceptor (YFP) photobleaching. Photobleaching of YFP was carried out with 
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515 nm laser line, by a single point activation module for rapid and efficient multi-region bleaching. 
Images were acquired without averaging. Image acquisition parameters were optimized for maximal 
signal-to-noise ratio and minimal phototoxicity. Images were 512 × 512 pixels, with a pixel width of 
92 – 110 nm. Z-stacks were collected from 3-4 µm optical slice, at 0.6 - 0.8µm steps. Mean FRET 
efficiency, Em, was then calculated using the equation Em = 1 − IDA/ID, where IDA is the peak of donor 
emission in the presence of the acceptor and ID is the peak after acceptor photobleaching. Detection 
of signals was done as described earlier (8). Briefly, regions of interest (ROIs) were marked at boutons 
that underwent YFP photobleaching. Average intensity of ROI was subtracted from background ROI 
intensity in close proximity to the bouton. All the boutons that exhibited acceptor photobleaching by 
>90% of initial fluorescence intensity were included in the analysis. Non-bleached boutons at the 
same image area were analyzed to ensure lack of non-specific photobleaching due to image 
acquisition. 
Co-immunoprecipitation. Adult mouse brain membranes were prepared as described previously (2) 
and solubilized in NP-40 lysis buffer (100mM NaCl, 20mM Tris, 0.5% Nonidet P-40, 1mM EDTA) 
supplemented with protease inhibitors (complete EDTA-free, Roche). After pre-clearing with protein 
A-agarose beads (Roche), solubilized brain membranes were incubated overnight at 4° with anti-
CaV2.2 (ACC-002, Alomone Labs) or anti-Syntaxin 1 (ANR-002, Alomone Labs) antibodies. 
Subsequently antibody/protein complexes were captured by incubation with Protein A-agarose beads 
for 40 min at 4°, washed six times in lysis buffer and eluted with 1x reducing SDS-PAGE sample 
buffer. For Western Blotting, protein samples were resolved using standard SDS–PAGE and probed 
with the primary antibodies anti-CaV2.2 (1:500, AB5154, Millipore), anti-Syntaxin 1 (1:1000, 
S1172, Sigma) anti-GABAB1 (1:500, ab55051, Abcam) and peroxidase-coupled secondary antibodies 
(1:10000, GE Healthcare Life Sciences) or the Clean Blot IP reagent (1:200, Thermo Fisher 
Scientific). The chemiluminescence detection kit SuperSignal West (Thermo Scientific) was used for 
visualization.  
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Chemical reagents. FM4-64 (SynaptoRed C2), FM1-43 (SynaptoGreen C4) and Advasep-7 were 
purchased from Biotium; CGP54626 and baclofen from Tocris; TTX from Alomon labs, kynurenic 
acid from Sigma-Aldrich, Calcium Green 488 BAPTA-1 AM from Invitrogen.  
Statistical analysis. Error bars shown in the figures represent standard error of the mean (s.e.m.). 
Where applicable, the number of experiments (cultures) or the number of boutons is defined by n. All 
the experiments were repeated at least in 3 different batches of cultures. One-way ANOVA analysis 
with post hoc Bonferroni’s was used to compare several conditions. Student’s un-paired, two-tailed 
t-test has been used in the experiments where two different populations of synapses were compared. 
Student’s paired, two-tailed t-test has been used in the experiments where before and after treatments 
were compared at the same population of synapses. * P < 0.05; ** P < 0.01; *** P < 0.001, ns – non 
significant.  
References: 
1. Slutsky I, Sadeghpour S, Li B, & Liu G (2004) Enhancement of synaptic plasticity through chronically 
reduced Ca2+ flux during uncorrelated activity. Neuron 44(5):835-849. 
2. Vigot R, et al. (2006) Differential compartmentalization and distinct functions of GABAB receptor 
variants. Neuron 50(4):589-601. 
3. Slomowitz E, et al. (2015) Interplay between population firing stability and single neuron dynamics in 
hippocampal networks. eLife 10.7554/eLife.04378. 
4. Laviv T, et al. (2011) Compartmentalization of the GABAB Receptor Signaling Complex Is Required 
for Presynaptic Inhibition at Hippocampal Synapses. The Journal of Neuroscience 31(35):12523-
12532. 
5. Greitzer-Antes D, et al. (2013) Tracking Ca2+-dependent and Ca2+-independent conformational 
transitions in syntaxin 1A during exocytosis in neuroendocrine cells. Journal of Cell Science 
126(13):2914-2923. 
6. Wang D, et al. (2011) Syntaxin Requirement for Ca2+-Triggered Exocytosis in Neurons and 
Endocrine Cells Demonstrated with an Engineered Neurotoxin. Biochemistry 50(14):2711-2713. 
7. Abramov E, et al. (2009) Amyloid-[beta] as a positive endogenous regulator of release probability at 
hippocampal synapses. Nat Neurosci 12(12):1567-1576. 
8. Laviv T, et al. (2010) Basal GABA Regulates GABA(B)R Conformation and Release Probability at 
Single Hippocampal Synapses. Neuron 67(2):253-267. 
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Supplementary Figures 
 
Figure S1. Washout of gabazine causes a decrease in mean firing rate after 2 days gabazine 
incubation. The average firing rate was reduced by 60% (P = 0.0011, paired, two-tailed t-test).  
Figure S2. Measuring synaptic vesicle exocytosis by FM dyes. (A) Experimental protocol to estimate 
the rate of synaptic vesicle exocytosis by FM dyes. (B) Acute application of CGP54626 increases 
the FM destaining rate (n = 688 – 762). (C) Application of CGP54626 during FM destaining does not 
prevent TTX48h-induced increase in the FM destaining rate (n = 305 - 321). Unpaired, two-tailed t-
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test. (D) Increase in the extracellular Ca2+ from 1.2 to 2.5 mM induced an increase in the FM 
destaining rate in 1a-/- (n = 250 - 295) and  CGP48h-treated (n = 270 - 310) cultures.  
 
 
Figure S3. Blockade of GABABRs prevents homeostatic decrease in Pr by gabazine. (A) 
Representative FM destaining rate curves of 80 synapses under control conditions (Cnt), 2 days 
after gabazine incubation (GBZ48h) and 2 days after concurrent gabazine and CGP54626 incubation 
((GBZ+CGP)48h) . (B) Effect of GBZ48h and (GBZ+CGP)48h on average destaining rate constants (n 
= 385 – 450, unpaired, two-tailed t-test). 
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Figure S4. Impaired basal GABABR-mediated inhibition in 1a–/– boutons. (A) Experimental protocol 
used to determine tonic inhibition. Synaptic vesicle recycling evoked by 30 AP @ 0.2 Hz was 
assessed before and 10 min after application of CGP54626 (1 µM). (B) Representative F images 
before and after CGP54626 application in WT, 1a–/– and 1b–/– cultures. Scale bar: 2 μm. (C-E) Tonic 
inhibition expressed as fold changes in F, D (FM-(+) puncta density) and S (total presynaptic 
strength, S = F  D) across synaptic populations in WT (n = 18), 1a–/– (n = 17) and 1b–/– (n = 17) 
cultures. One way ANOVA with post hoc Bonferroni’s multiple comparison tests. 
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Figure S5. Acute effect of CGP54626 on mEPSCs. (A) Representative traces of mEPSCs in control 
and after acute (10 min) application of CGP54626. Scale bar: 20 pA, 0.5 sec. (B-C) Cumulative 
distributions of the mEPSC peak amplitude (B) and inter-event intervals (D) before and after CGP 
application (n = 9). (D-E) Average mean peak amplitude (D, P > 0.7) and frequency (E, P > 0.2) of 
mEPSCs (the same experiments as in B-C). Paired, two-tailed t-tests.  
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Figure S6. Postsynaptic scaling of mEPSC amplitude requires active GABABRs. (A) Representative 
traces of mEPSCs in control, after TTX48h, CGP48h and (TTX+CGP)48h pre-incubation. Scale bar: 40 
pA, 0.5 sec. (B-C) Cumulative distributions of the mEPSC peak amplitude (B) and inter-event 
intervals (D) under control (n = 21), after TTX48h (n = 29), CGP48h (n = 27) and (TTX+CGP)48h (n = 
17) conditions. Differences between the control and TTX48h conditions for the displayed mEPSC 
amplitude cumulative distributions are statistically significant (P < 0.05, K-S test). Differences 
between mEPSC inter-event interval distributions (P = 0.95, K-S test) are not significant. (D-E) 
Average mean peak amplitude (D) and frequency (E) of mEPSCs (the same experiments as in B-
C). ANOVA analysis with post hoc Bonferroni’s multiple comparison tests.  
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Figure S7. Chronic inactivity by TTX triggers a reduction in short-term synaptic facilitation measured 
between paired of neurons. (A) Double-patch recordings of evoked AMPAR-mediated EPSCs at -70 
mV (in the presence of 50 µM AP-5). Neurons were stimulated by single (0.1 Hz) and bursting (bursts 
of 5 APs, inter-spike-interval 30, 20 and 10 ms, inter-burst-interval 10 sec) inputs in control and 
TTX48h-treated cultures. (B) Short-term facilitation of EPSC charge transfer (burst/single ratio, 
calculated as Qburst/Qsingle*5) is lower in TTX48h-treated cultures (n = 8). 
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Figure S8. GB1b-containing GABABRs mediate postsynaptic scaling of mEPSC amplitude. (A) 
Representative traces of mEPSCs in control and TTX48h 1b-/- cultures. Scale bar: 20 pA, 0.5 sec. (B-
C) Cumulative distributions of the mEPSC peak amplitude (B) and inter-event intervals (D) in control 
(n = 13) and TTX48h-treated (n = 13) cultures. (D-E) Average mean peak amplitude (D, P > 0.6) and 
frequency (E, P > 0.5) of mEPSCs (the same experiments as in B-C). Unpaired, two-tailed t-tests.  
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Figure S9. Endogenous GABABRs co-immunoprecipitate with syntaxin-1 and CaV2.2. (A-B) 
Solubilized brain membranes from WT, 1b-/- and 1-/- mice were immunoprecipitated (IP) with anti-
syntaxin-1 (A) and anti-CaV2.2 (B) antibodies and analyzed by western blotting with the indicated 
antibodies. Of note, the anti-GB1 antibody recognizes the common C-terminus of GB1a and GB1b.  
Asterisk indicates a cross-reacting band visible after the long exposure required for detection of 
GABABRs in anti-syntaxin-1 IPs. Left panels show input brain membranes used for 
immunoprecipitation. MW, molecular weight. 
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Figure S10. Calcium transients evoked by single spikes are not saturated in 1a-/- presynaptic 
boutons. Calcium transients evoked by spike bursts (5 spikes at 100 Hz, 5 sec inter-burst-interval) 
were significantly higher than those evoked by single spikes (n = 10, paired, two-tailed t-test). 
 
 
 
 
Figure S11. GB1a-PCT domain determines GB1a/GB2 and GB1a/Synt1a inter-molecular changes by 
chronic inactivity. (A) Deletion of PCT domain increases GB1aCer/Synt1aYFP FRET efficiency and 
abolishes TTX48h-induced FRET changes (n = 58 - 69). (B) Effect of TTX48h on Em between 
GB1aYFP/GB2Cer in GB1aWT (n = 17 - 29) and GB1aPCT (n = 24 - 28) expressing neurons. Unpaired, 
two-tail, student t-tests. 
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